{
  "meta": {
    "title": "00353_Late_Night_Pyq_Pyt_Obg-2",
    "url": "https://brainandscalpel.vercel.app/00353-late-night-pyq-pyt-obg-2-f016a715.html",
    "scrapedAt": "2025-11-29T17:29:23.504Z"
  },
  "questions": [
    {
      "id": 6056,
      "choices": [
        {
          "id": 24194,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Imperforate hymen</span></span></span></p>"
        },
        {
          "id": 24195,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Semilunar hymen</span></span></span></p>"
        },
        {
          "id": 24196,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Septate hymen</span></span></span></p>"
        },
        {
          "id": 24197,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Annular hymen</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the type of hymen shown in the image? </span></span>(NEET PG 2022)</p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/neet-pg-obg-2022-1.jpg\" style=\"height:240px; width:300px\" /></p>",
      "unique_key": "Q5070442",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585177,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Septate hymen </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given image is suggestive of the septate hymen.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The hymen is the membranous vestige of the junction between the sino-vaginal bulbs and the urogenital sinus, which perforates during fetal life to establish a connection between the vaginal lumen and the perineum.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Defective perforation of this structure may result in the following variants of hymen:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Imperforate hymen</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Without any opening (presents as cryptomenorrhea at puberty)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Micro-perforate hymen</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Tiny opening</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Annular hymen</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Oval central opening</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Septate hymen</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Two lateral openings partitioned by a bridge of hymenal tissue (May have difficulty in intercourse, placement of a tampon)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Naviculate hymen</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Boat-like opening</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Imperforate hymen</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: An imperforate hymen has no opening at all and often presents as cryptomenorrhea (accumulation of menstrual blood behind the hymen) at puberty.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Semilunar hymen</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: A semilunar hymen has a crescent-shaped opening and is not depicted in the image.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Annular hymen</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: An annular hymen has an oval central opening and does not match the septate appearance in the image.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A septate hymen is characterized by two lateral openings partitioned by a bridge of hymenal tissue, which may lead to difficulties with intercourse or tampon use.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/15/untitled-79.jpg\" style=\"height:374px; width:500px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 18, DC Dutta&rsquo;s Textbook of Gynecology 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 24196,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6114,
      "choices": [
        {
          "id": 24425,
          "text": "<p><span style=\"font-size:12pt;\">3, 1, 2, 4</span></p>"
        },
        {
          "id": 24426,
          "text": "<p><span style=\"font-size:12pt;\">3, 2, 4, 1</span></p>"
        },
        {
          "id": 24427,
          "text": "<p><span style=\"font-size:12pt;\">2, 4, 3, 1</span></p>"
        },
        {
          "id": 24428,
          "text": "<p><span style=\"font-size:12pt;\">2, 4, 1, 3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Consider the following actions under AMTSL. Arrange them in the right order?&nbsp;</span>(INICET NOV 2022)</p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">Uterine tone assessment</span></li><li><span style=\"font-size:12pt;\">Give uterotonic (oxytocin 10 mg)</span></li><li><span style=\"font-size:12pt;\">Exclude the presence of another fetus</span></li><li><span style=\"font-size:12pt;\">Controlled cord traction</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\">AMTSL- Active management of the third stage of labor.</span></p>",
      "unique_key": "Q5244659",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585198,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) 3, 2, 4, 1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Active Management of 3<sup>rd</sup> Stage of Labor</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Active Management of the Third Stage of Labor (AMTSL) is a set of interventions aimed at preventing postpartum hemorrhage (PPH). The correct order of actions is:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>3. Exclude the presence of another fetus</strong>: Ensure there is no additional fetus before administering any uterotonic.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>2. Give uterotonic (oxytocin 10 mg)</strong>: Administer a uterotonic drug to help the uterus contract and reduce bleeding. It is given after the delivery of baby.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>4. Controlled cord traction</strong>: Perform controlled traction on the umbilical cord to deliver the placenta.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>1. Uterine tone assessment</strong>:<strong> </strong>assess the uterine tone every 15 minutes to detect uterine atony.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The steps of Active Management of the Third Stage of Labor (AMTSL) should be followed in a specific order: exclude the presence of another fetus, administer a uterotonic, perform controlled cord traction, and then assess the uterine tone.</span></p>",
      "correct_choice_id": 24426,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20480,
      "choices": [
        {
          "id": 81882,
          "text": "<p><span style=\"font-size:12pt;\">Tubal ligation</span></p>"
        },
        {
          "id": 81883,
          "text": "<p><span style=\"font-size:12pt;\">Asherman syndrome</span></p>"
        },
        {
          "id": 81884,
          "text": "<p><span style=\"font-size:12pt;\">Endocervical polyp</span></p>"
        },
        {
          "id": 81885,
          "text": "<p><span style=\"font-size:12pt;\">Subserosal fibroid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In which of the following conditions, hysteroscopy can be done? (NEET PG 2023)</span></p>",
      "unique_key": "Q7270227",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585157,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Asherman syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Hysteroscopy is the treatment of choice in Asherman syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Asherman Syndrome</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">These are intra-uterine adhesions</span></li><li><span style=\"font-size:12pt;\">They usually follow a history of sharp curettage</span></li><li><span style=\"font-size:12pt;\">Symptoms are hypomenorrhea, secondary amenorrhoea and secondary infertility</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Diagnosis –</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">TVS: broken/ irregular endometrium</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">HSG: space filling defect is seen (moth eaten appearance)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Ix of choice: Hysteroscopy</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Treatment - Hysteroscopic adhesiolysis</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/10/screenshot-2024-08-10-175609.png\" alt=\"\" width=\"400\" height=\"537\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Tubal ligation</strong>: Tubal ligation is done via laparoscopy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Endocervical polyp</strong>: In Endocervical polyps’ cases surgical ligation and excision can be done if severe bleeding is expected. Hysteroscopy can help visualisation and assessment but it is not the primary method for managing endocervical polyps.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Subserosal fibroid:</strong> In cases of Subserosal fibroids an MRI helps in detailed mapping of the fibroids if a myomectomy is planned.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Hysteroscopy is the treatment of choice in Asherman syndrome.</span></p>",
      "correct_choice_id": 81883,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23222,
      "choices": [
        {
          "id": 92852,
          "text": "<p><span style=\"font-size:12pt;\">At eight weeks the embryo is bipotent</span></p>"
        },
        {
          "id": 92853,
          "text": "<p><span style=\"font-size:12pt;\">Wolffian duct develops into epididymis and vas deferens on either side of the body</span></p>"
        },
        {
          "id": 92854,
          "text": "<p><span style=\"font-size:12pt;\">Mullerian inhibiting substance inhibits mullerian duct</span></p>"
        },
        {
          "id": 92855,
          "text": "<p><span style=\"font-size:12pt;\">Dihydrotestosterone leads to the development of secondary sexual characters and external genitalia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements is&nbsp;not true&nbsp;about male sexual development? (INICET MAY 2023)</span></p>",
      "unique_key": "Q4868898",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585183,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) At eight weeks the embryo is bipotent</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">At eight weeks of gestation, the embryo is no longer bipotent. The term \"bipotent\" refers to the embryo's capability to develop into either male or female structures, which is true up until about the sixth week of development. By the eighth week, sexual differentiation is already underway, with the influence of the SRY gene causing the gonads to differentiate into testes in 46XY embryos. This differentiation results in a shift away from bipotency, making the embryo committed to developing male characteristics.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Wolffian duct develops into epididymis and vas deferens on either side of the body</strong>: This statement is true. The Wolffian ducts, under the influence of testosterone, develop into the male reproductive structures including the epididymis and vas deferens.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Mullerian inhibiting substance inhibits Mullerian duct</strong>: This statement is true. Mullerian inhibiting substance (MIS), also known as anti-Mullerian hormone (AMH), is produced by Sertoli cells in the testes and inhibits the development of the Mullerian ducts, which would otherwise develop into female reproductive structures such as the uterine tubes and uterus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Dihydrotestosterone leads to the development of secondary sexual characters and external genitalia</strong>: This statement is true. Dihydrotestosterone (DHT), a potent metabolite of testosterone, is crucial for the development of male external genitalia and secondary sexual characteristics such as facial hair and a deeper voice.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">At eight weeks of gestation, the embryo is no longer bipotent; sexual differentiation has already commenced.</span></p>",
      "correct_choice_id": 92852,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6012,
      "choices": [
        {
          "id": 24018,
          "text": "<p><span style=\"font-size:12pt;\">Crown rump length by USG</span></p>"
        },
        {
          "id": 24019,
          "text": "<p><span style=\"font-size:12pt;\">Adding 280 days to the LMP</span></p>"
        },
        {
          "id": 24020,
          "text": "<p><span style=\"font-size:12pt;\">Fundus examination</span></p>"
        },
        {
          "id": 24021,
          "text": "<p><span style=\"font-size:12pt;\">Adding 256 days to the LMP</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old woman on oral contraceptives for the past 6 months presents with 6 weeks of amenorrhea. What would be the best method of assessing the gestational age of this patient? (NEET PG 2021)</span></p>",
      "unique_key": "Q1328506",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585216,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Crown rump length by USG</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Crown-Rump Length (CRL) by Ultrasound:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The most accurate method for determining gestational age in the first trimester is by measuring the Crown-Rump Length (CRL) on ultrasound. This method is reliable as it directly measures the embryo or fetus and provides a precise gestational age.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Adding 280 days to the Last Menstrual Period (LMP):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">This method, known as Naegele’s rule, is commonly used but assumes a regular 28-day menstrual cycle and may not be accurate for women with irregular cycles or those using contraceptives.</span></li><li><span style=\"font-size:12pt;\">It is less reliable in this patient who has been on oral contraceptives, which can alter the regularity of menstrual cycles.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Fundus Examination:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Palpation of the uterine fundus is a physical examination method to estimate gestational age. However, it is less accurate in the first trimester and typically used in the second and third trimesters.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Adding 256 days to the LMP:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">This method is not standard practice and is less commonly used compared to adding 280 days to the LMP.</span></li><li><span style=\"font-size:12pt;\">It would be even less reliable in this patient who has been on oral contraceptives.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The most accurate method for determining gestational age in the first trimester is the measurement of Crown-Rump Length (CRL) on ultrasound.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 475, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24018,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6052,
      "choices": [
        {
          "id": 24178,
          "text": "<p><span style=\"font-size:12pt;\">Magnesium sulphate toxicity</span></p>"
        },
        {
          "id": 24179,
          "text": "<p><span style=\"font-size:12pt;\">Diabetic ketoacidosis</span></p>"
        },
        {
          "id": 24180,
          "text": "<p><span style=\"font-size:12pt;\">Postpartum eclampsia</span></p>"
        },
        {
          "id": 24181,
          "text": "<p><span style=\"font-size:12pt;\">Peripartum cardiomyopathy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 22y type 1 DM is in the post operative ward following a cesarean done for failed induction (for preeclampsia with severe features). She complains of drowsiness and altered sensorium. She is on maintenance MgSO4 infusion and on IV infusion of insulin. On examination, her PR is 70/ min. BP is 140/ 98 mmHg. RR is 10/min. Auscultation of lungs reveals bilateral normal air entry. Abdominal examination reveals a firm uterus with normal tenderness. Pfannenstiel scar is intact and there is no significant vaginal bleeding. B/l patellar reflexes are absent. A urine dipstick for protein and sugar is negative and a capillary glucose sample is 270 mg%. The suspected diagnosis is?&nbsp;(NEET PG 2022)</span></p>",
      "unique_key": "Q3994813",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585173,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Magnesium sulphate toxicity</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The given clinical scenario and examination finding of B/L absent knee reflex and respiratory depression following magnesium sulfate (MgSO4) administration for preeclampsia suggest the cause of her condition to be magnesium sulfate toxicity.</span></li><li><span style=\"font-size:12pt;\">MgSO4 is used as an anticonvulsant in the management of eclampsia and as prophylaxis in severe preeclampsia.</span></li><li><span style=\"font-size:12pt;\">The therapeutic level of magnesium in eclampsia is 4-7 mEq/L</span></li><li><span style=\"font-size:12pt;\">When on MgSO4, patients must be monitored for magnesium toxicity:</span></li><li><span style=\"font-size:12pt;\">A woman on MgSO4 for management of eclampsia requires the following to be checked for Mg toxicity:</span><ol><li><span style=\"font-size:12pt;\">Deep tendon reflexes</span></li><li><span style=\"font-size:12pt;\">Respiratory Rate</span></li><li><span style=\"font-size:12pt;\">Urine Output</span></li></ol></li><li><span style=\"font-size:12pt;\">Magnesium toxicity occurs at these levels</span><ul><li><span style=\"font-size:12pt;\">At &gt; 7-10 mEq/L: Loss of DTR</span></li><li><span style=\"font-size:12pt;\">10 - 12 mEq/L: Respiratory depression</span></li><li><span style=\"font-size:12pt;\">25 mEq/L: Cardiac arrest</span></li></ul></li><li><span style=\"font-size:12pt;\">Antidote for Mg toxicity: Ca gluconate (1 g IV)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Diabetic ketoacidosis</strong>: This is unlikely as urine for sugars is absent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Postpartum eclampsia</strong>: This is unlikely as there is no history of seizures</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Peripartum cardiomyopathy</strong>: There is no evidence of cardiac failure and hence this is also unlikely</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">When administering magnesium sulfate for preeclampsia, it is critical to monitor for signs of magnesium toxicity, which include loss of deep tendon reflexes, respiratory depression, and cardiac arrest. The antidote for magnesium toxicity is calcium gluconate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 1860, Williams Obstetrics, 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24178,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5680,
      "choices": [
        {
          "id": 22692,
          "text": "<p><span style=\"font-size:12pt;\">Hypertension diagnosed at 10 weeks of gestation&nbsp;</span></p>"
        },
        {
          "id": 22693,
          "text": "<p><span style=\"font-size:12pt;\">Diabetic retinopathy</span></p>"
        },
        {
          "id": 22694,
          "text": "<p><span style=\"font-size:12pt;\">Diabetic nephropathy&nbsp;</span></p>"
        },
        {
          "id": 22695,
          "text": "<p><span style=\"font-size:12pt;\">Episode of seizure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Pregnant women with which of the following is called systemic hypertension?&nbsp;(INICET MAY 2017) &nbsp; &nbsp; &nbsp; &nbsp;</span></p>",
      "unique_key": "Q1413020",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585180,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Hypertension diagnosed at 10 weeks of gestation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Systemic hypertension in pregnancy is classified as chronic hypertension if it is diagnosed in the first trimester or if hypertension persists beyond 12 weeks postpartum. Hypertension present before pregnancy or diagnosed before the 20th week of gestation also qualifies as chronic hypertension. This is distinct from gestational hypertension, which develops after 20 weeks of gestation in a previously normotensive woman.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Chronic Hypertension:</strong> Defined as blood pressure of ≥ 140/90 mm Hg that was present before pregnancy or diagnosed before the 20th week of gestation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Diabetic retinopathy:</strong> This condition is a complication of diabetes affecting the eyes, not a direct indicator of systemic hypertension.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Diabetic nephropathy:</strong> This is a complication of diabetes that affects the kidneys and can be associated with hypertension, but it is not specific to the definition of systemic hypertension in pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Episode of seizure:</strong> Seizures in the context of pregnancy are associated with eclampsia, a severe form of preeclampsia, but do not directly define systemic hypertension.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Systemic hypertension in pregnancy is diagnosed if high blood pressure is present before pregnancy, is diagnosed before 20 weeks of gestation, or persists beyond 12 weeks postpartum.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 1778, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 22692,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55310,
      "choices": [
        {
          "id": 220701,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">NTD</span></span></span></p>"
        },
        {
          "id": 220702,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anencephaly</span></span></span></p>"
        },
        {
          "id": 220703,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Down syndrome</span></span></span></p>"
        },
        {
          "id": 220704,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Duodenal atresia</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Banana sign and lemon sign are seen in? (FMGE JULY 2024)</span></span></span></p>",
      "unique_key": "Q6962957",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585168,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) NTD</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Banana sign and lemon sign are ultrasound findings typically associated with neural tube defects (NTD), more specifically <strong>spina bifida.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Banana sign</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This refers to the excessive curvature of the cerebellum, which appears compressed and curved, resembling a banana.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lemon sign</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is characterized by the pinching of the frontal bones of the fetal skull, causing it to appear like a lemon when viewed from the front. These signs are indicative of the changes in intracranial pressure and structure caused by spina bifida.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Anencephaly</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This condition involves the absence of a major portion of the brain, skull, and scalp, and is often described as having a &quot;frog-like&quot; face due to the absence of the cranial vault.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Down syndrome</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Down syndrome has various ultrasound markers, but these are typically subtle and referred to as soft </span><span style=\"font-size:12.0pt\">tissue </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">markers, not including the banana or lemon signs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Duodenal atresia</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This condition is characterized by the &quot;double bubble&quot; sign on ultrasound, indicating a blockage in the duodenum, and is not associated with the banana or lemon signs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Banana sign and lemon sign are ultrasound findings seen in neural tube defects (NTD), particularly in cases of spina bifida.</span></span></span></p>",
      "correct_choice_id": 220701,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5828,
      "choices": [
        {
          "id": 23282,
          "text": "<p><span style=\"font-size:12pt;\">Trichomonas vaginalis</span></p>"
        },
        {
          "id": 23283,
          "text": "<p><span style=\"font-size:12pt;\">Gardnerella vaginalis</span></p>"
        },
        {
          "id": 23284,
          "text": "<p><span style=\"font-size:12pt;\">Neisseria gonorrhea</span></p>"
        },
        {
          "id": 23285,
          "text": "<p><span style=\"font-size:12pt;\">Candida albicans</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient came to the gynecology OPD with complaints of foul-smelling frothy vaginal discharge and intense itching. On examination, the cervix was spotted and had the appearance of a strawberry. Identify the causative organism? (NEET PG 2020)</span></p>",
      "unique_key": "Q8193162",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585188,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Trichomonas vaginalis</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Intense vaginal itching and foul-smelling greenish discharge are suggestive of Trichomonas vaginalis infection.</span></li><li><span style=\"font-size:12pt;\">Strawberry like appearance of the cervix helps in establishing the diagnosis.</span></li><li><span style=\"font-size:12pt;\">On vaginal smear, flagellated organism (T. vaginalis is seen)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Best understood by this table given below</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/14/2_page_1.jpg\" alt=\"\" width=\"1000\" height=\"1098\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Trichomonas vaginalis infection is characterized by foul-smelling, frothy yellowish-green discharge and a strawberry-like appearance of the cervix.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 554, DC Dutta’s Textbook of gynecology 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23282,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5880,
      "choices": [
        {
          "id": 23490,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clomiphine citrate</span></span></span></p>"
        },
        {
          "id": 23491,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Letrozole</span></span></span></p>"
        },
        {
          "id": 23492,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ulipristal</span></span></span></p>"
        },
        {
          "id": 23493,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Laparoscopic ovarian drilling</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following can be used for the treatment of PCOD except?&nbsp;</span></span>(INICET MAY 2020)</p>",
      "unique_key": "Q3179558",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585212,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Ulipristal</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ulipristal is not used for the treatment of PCOD. </span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a selective progesterone receptor modulator.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is used as an emergency contraceptive and in medical management of fibroids</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Clomiphene</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Clomiphene is an anti-estrogen used in ovulation induction in women with PCOS (1<sup>st</sup> line agent) and infertility</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gonadotropins can also be used in PCOS with infertility in those who have clomiphene resistance (2<sup>nd</sup> line therapy)</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Letrozole</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: But nowadays Letrozole (aromatase inhibitor) is the drug for ovulation induction in PCOS with infertility. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Laparoscopic ovarian drilling:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is recommended as second-line therapy in PCOS</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ulipristal</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is not used for the treatment of Polycystic Ovary Syndrome (PCOS). It is a selective progesterone receptor modulator primarily used for emergency contraception and managing uterine fibroids.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 244, DC Dutta&rsquo;s Textbook of Gynecology 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23492,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5925,
      "choices": [
        {
          "id": 23670,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Blighted ovum</span></span></span></p>"
        },
        {
          "id": 23671,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">﻿﻿﻿Missed abortion</span></span></span></p>"
        },
        {
          "id": 23672,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">﻿﻿﻿Ectopic pregnancy</span></span></span></p>"
        },
        {
          "id": 23673,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">﻿﻿﻿Hydatidiform mole</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A primigravida in her 10th week of gestation presents with spotting. On examination, the uterus corresponds to 12 weeks. Transvaginal ultrasound was done and it is given below. What is your diagnosis?&nbsp;</span></span>(INICET MAY 2021)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/1_Y739Z2T.jpg\" style=\"height:253px; width:300px\" /></span></span></span></span></p>",
      "unique_key": "Q2415847",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585174,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Hydatidiform mole</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"><br />\r\n<span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The typical &lsquo;Snowstorm appearance&rsquo; on ultrasound is indicative of a hydatidiform mole. This appearance is characteristic of a complete molar pregnancy, where there is a proliferation of abnormal tissue instead of a viable embryo.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Complete Mole:</span></strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ultrasound Finding:</span></strong><span style=\"font-size:12.0pt\"> Snowstorm appearance with diffuse, heterogeneous echogenicity.</span></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Genetics:</span></strong><span style=\"font-size:12.0pt\"> Diploid with only paternal genetic material. It can occur due to either:</span></span></span>\r\n\t\t<ul style=\"list-style-type:square\">\r\n\t\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">One sperm fertilizing an empty or inactivated ovum (androgenesis), leading to 46XX or 46XY.</span></span></span></li>\r\n\t\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Two sperm fertilizing an empty ovum (dispermy), also leading to 46XX or 46XY.</span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Clinical Management:</span></strong><span style=\"font-size:12.0pt\"> Suction evacuation is the standard treatment.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Partial Mole:</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Genetics:</span></strong><span style=\"font-size:12.0pt\"> Triploid, with 69XXX or 69XXY, resulting from two sperm fertilizing one ovum.</span></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Clinical Appearance:</span></strong><span style=\"font-size:12.0pt\"> Typically has a more complex presentation with an abnormal fetus.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Blighted ovum:</span></strong><span style=\"font-size:12.0pt\"> Also known as an anembryonic pregnancy, this occurs when a gestational sac forms but no embryo is visible. It does not present with the Snowstorm appearance and usually lacks the pronounced proliferation of tissue seen in a hydatidiform mole.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Missed abortion:</span></strong><span style=\"font-size:12.0pt\"> This involves the retention of an embryo or fetus with no detectable heartbeat or growth. The ultrasound findings typically show a non-viable fetus without the characteristic snowstorm pattern of a hydatidiform mole.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Ectopic pregnancy:</span></strong><span style=\"font-size:12.0pt\"> This occurs when a fertilized egg implants outside the uterus, often in the fallopian tubes. It would not present with the Snowstorm appearance but rather show a gestational sac or products of conception in an abnormal location.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"><br />\r\n<span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The &#39;Snowstorm appearance&#39; on transvaginal ultrasound is characteristic of a hydatidiform mole.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 225, DC Dutta&rsquo;s Textbook of Obstetrics 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23673,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55335,
      "choices": [
        {
          "id": 220801,
          "text": "<p><span style=\"font-size:12.0pt;\">Beta hCG</span></p>"
        },
        {
          "id": 220802,
          "text": "<p><span style=\"font-size:12.0pt;\">Estradiol</span></p>"
        },
        {
          "id": 220803,
          "text": "<p><span style=\"font-size:12.0pt;\">Progesterone</span></p>"
        },
        {
          "id": 220804,
          "text": "<p><span style=\"font-size:12.0pt;\">Estriol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Marker for ectopic pregnancy is? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q4322053",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585176,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Beta hCG</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct answer is <strong>Beta hCG</strong> (Human Chorionic Gonadotropin). Beta hCG is a hormone produced by the placenta during pregnancy. In the context of an ectopic pregnancy, which is a pregnancy located outside the uterine cavity (commonly in the fallopian tubes), the measurement of Beta hCG levels is crucial for diagnosis and management.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Beta hCG</strong>: In a normal intrauterine pregnancy, Beta hCG levels typically double every 48-72 hours. In ectopic pregnancies, these levels usually rise more slowly. Additionally, Beta hCG levels are used to determine the mode of management for unruptured ectopic pregnancies (medical, surgical, or expectant management) and to assess the discriminatory zone, which is the level of Beta hCG at which an intrauterine pregnancy should be visible on ultrasound.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Estradiol</strong>: This is a form of estrogen, a hormone involved in the regulation of the menstrual cycle and pregnancy, but it is not a marker for ectopic pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Progesterone</strong>: This hormone supports the early stages of pregnancy by preparing the uterine lining for implantation, but it is not specifically used to diagnose ectopic pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Estriol</strong>: Another form of estrogen produced during pregnancy, it is not used as a marker for ectopic pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Beta hCG&nbsp;</strong>is the primary marker used to diagnose and manage ectopic pregnancies, providing essential information about pregnancy location and viability.</span></p>",
      "correct_choice_id": 220801,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "FMGE",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5814,
      "choices": [
        {
          "id": 23226,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wait and watch for 4 weeks</span></span></span></p>"
        },
        {
          "id": 23227,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Repeat TVS after one week</span></span></span></p>"
        },
        {
          "id": 23228,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum HCG levels</span></span></span></p>"
        },
        {
          "id": 23229,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medical intervention</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A lady with 7 weeks amenorrhea presented with slight vaginal spotting. Crown Rump Length was 5 mm with a well-formed gestational sac with a calculated gestational age of 5.6 weeks on TVS. What is the next line of management?&nbsp;</span></span></span>(INICET NOV 2018)</p>",
      "unique_key": "Q7021997",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585182,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Repeat TVS after one week</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the case described, the patient has a gestational sac and a crown-rump length (CRL) of 5 mm, with a calculated gestational age of 5.6 weeks based on transvaginal sonography (TVS). The guidelines for assessing early pregnancy viability are:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Absence of an embryo at a mean sac diameter (MSD) &ge; 25 mm indicates an anembryonic pregnancy.</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Absence of cardiac activity at a CRL &ge; 7 mm indicates a non-viable pregnancy.</span></strong></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In this scenario, the CRL is 5 mm, which is below the threshold where the absence of cardiac activity would indicate a non-viable pregnancy (&ge; 7 mm). There is no mention of cardiac activity in the current ultrasound findings, so it is crucial to monitor the pregnancy further before making any conclusions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The best course of action is to repeat the transvaginal ultrasound after one week to check for the presence of cardiac activity and further development of the embryo.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This approach allows for a more accurate assessment of the viability of the pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Wait and watch for 4 weeks:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Waiting for 4 weeks without further evaluation could delay necessary medical intervention and is not recommended for timely assessment of pregnancy viability.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Serum HCG levels:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While measuring serum HCG levels can provide some information about the progression of the pregnancy, it is less specific than ultrasound for determining viability, particularly in the context of assessing cardiac activity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Medical intervention:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Immediate medical intervention is not warranted at this stage without further evidence. The repeat ultrasound will provide more clarity on whether intervention is needed.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In early pregnancy with a CRL of less than 7 mm and no documented cardiac activity, the best approach is to repeat the transvaginal ultrasound after one week to reassess for the presence of cardiac activity and viability of the pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: William&rsquo;s textbook of obstetrics 26<sup>th</sup> edition pg 645</span></strong></span></span></p>",
      "correct_choice_id": 23227,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5954,
      "choices": [
        {
          "id": 23786,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clindamycin</span></span></span></p>"
        },
        {
          "id": 23787,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">﻿﻿Metronidazole</span></span></span></p>"
        },
        {
          "id": 23788,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cotrimoxazole</span></span></span></p>"
        },
        {
          "id": 23789,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Azithromycin</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 24-year-old female presents with complaints of foul-smelling vaginal discharge. Drug of choice to treat this condition is?&nbsp;</span></span>(INICET MAY 2021)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/1_KhxwfGV.jpg\" style=\"height:299px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q6774384",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585187,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Metronidazole</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"><br />\r\n<span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient presents with foul-smelling vaginal discharge, which is a common symptom of bacterial vaginosis (BV). In bacterial vaginosis, the correct treatment is <strong>Metronidazole</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Bacterial vaginosis</span></strong><span style=\"font-size:12.0pt\"> is often caused by an imbalance in the normal bacterial flora of the vagina, commonly involving Gardnerella vaginalis. The condition is diagnosed using Amsel&#39;s Criteria, which include:</span></span></span>\r\n\r\n\t<ol>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Thin, white homogenous vaginal discharge</span></strong><span style=\"font-size:12.0pt\">: The discharge is typically thin and white, and may have a fishy odor.</span></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">pH of Vaginal fluid &gt; 4.5</span></strong><span style=\"font-size:12.0pt\">: This elevated pH level is higher than the normal acidic environment of the vagina.</span></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Fishy odor of discharge on adding 10% KOH (Whiff test)</span></strong><span style=\"font-size:12.0pt\">: The discharge develops a characteristic fishy odor when mixed with potassium hydroxide.</span></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Presence of Clue cells on microscopy</span></strong><span style=\"font-size:12.0pt\">: Clue cells are vaginal epithelial cells that have a stippled appearance due to adherence of bacteria.</span></span></span></li>\r\n\t</ol>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Metronidazole is the first-line treatment for bacterial vaginosis, and it is typically administered as oral tablets (500 mg twice daily for 7 days).</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Clindamycin</span></strong><span style=\"font-size:12.0pt\">: While Clindamycin can be used to treat bacterial vaginosis, it is generally not the first choice. Metronidazole is preferred due to its effectiveness and established use.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Cotrimoxazole</span></strong><span style=\"font-size:12.0pt\">: This antibiotic is used for a variety of bacterial infections but is not effective for bacterial vaginosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Azithromycin</span></strong><span style=\"font-size:12.0pt\">: This is a macrolide antibiotic used primarily for sexually transmitted infections such as chlamydia and is not used for bacterial vaginosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"><br />\r\n<span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The drug of choice for treating bacterial vaginosis is Metronidazole.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 554, DC Dutta&rsquo;s Textbook of gynecology 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23787,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5897,
      "choices": [
        {
          "id": 23558,
          "text": "<p><span style=\"font-size:12pt;\">106 mg/dL</span></p>"
        },
        {
          "id": 23559,
          "text": "<p><span style=\"font-size:12pt;\">126 mg/dL</span></p>"
        },
        {
          "id": 23560,
          "text": "<p><span style=\"font-size:12pt;\">116 mg/dL</span></p>"
        },
        {
          "id": 23561,
          "text": "<p><span style=\"font-size:12pt;\">130 mg/dL</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">You discover that there is evidence of cardiac malformation in a fetus during a routine US scan at 16 weeks. What is the minimum level of fasting blood sugar at which you can suspect overt diabetes?&nbsp;</span>(NEET PG 2019)</p>",
      "unique_key": "Q8189139",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585164,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) 126 mg/dL</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Overt diabetes in a patient is diagnosed based on specific blood glucose levels. The criteria for diagnosing overt diabetes are:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Fasting blood sugar:</strong> ≥ 126 mg/dL</span></li><li><span style=\"font-size:12pt;\"><strong>Random blood sugar:</strong> ≥ 200 mg/dL</span></li><li><span style=\"font-size:12pt;\"><strong>HbA1c:</strong> ≥ 6.5%</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">During pregnancy, maternal hyperglycemia, especially during the first trimester when organogenesis occurs, increases the risk of fetal congenital malformations, including cardiac malformations. This is particularly true for women with pre-gestational diabetes, not gestational diabetes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. 106 mg/dL</strong>: This is incorrect. A fasting blood sugar level of 106 mg/dL does not meet the threshold for diagnosing overt diabetes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. 116 mg/dL</strong>: This is incorrect. A fasting blood sugar level of 116 mg/dL is higher than normal but still below the threshold for diagnosing overt diabetes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. 130 mg/dL</strong>: This is incorrect. Although higher than the threshold, the minimum level to suspect overt diabetes is 126 mg/dL, not 130 mg/dL.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Overt diabetes in pregnancy is diagnosed with a fasting blood sugar level of ≥ 126 mg/dL, and maternal hyperglycemia.</span></p>",
      "correct_choice_id": 23559,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "DiagnosisBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47227,
      "choices": [
        {
          "id": 188519,
          "text": "<p><span style=\"font-size:12.0pt;\">16 weeks</span></p>"
        },
        {
          "id": 188520,
          "text": "<p><span style=\"font-size:12.0pt;\">18 weeks</span></p>"
        },
        {
          "id": 188521,
          "text": "<p><span style=\"font-size:12.0pt;\">20 weeks</span></p>"
        },
        {
          "id": 188522,
          "text": "<p><span style=\"font-size:12.0pt;\">24 weeks</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Immediately following the delivery, the uterus will correspond to how many weeks of gestational age? (FMGE JULY 2023)</span></p>",
      "unique_key": "Q6214811",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585215,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 20 weeks</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Immediately after delivery, the uterus contracts and shrinks in size, positioning itself just below the umbilicus. This position is equivalent to the uterus at around 20 weeks of gestation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The uterus's rapid involution postpartum helps in controlling bleeding and facilitating the return to its non-pregnant state.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Immediately after delivery, the uterus corresponds to the size and position of a 20-week gestation, lying just below the umbilicus.</span></p>",
      "correct_choice_id": 188521,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5661,
      "choices": [
        {
          "id": 22616,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">9-11 weeks</span></span></span></span></p>"
        },
        {
          "id": 22617,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">12-14 weeks</span></span></span></span></p>"
        },
        {
          "id": 22618,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">15-20 weeks</span></span></span></span></p>"
        },
        {
          "id": 22619,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">22-28 weeks</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Quadruple testing is done during?</span></span> <span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NEET PG 2018)</span></span></p>",
      "unique_key": "Q6689393",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585171,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) 15-20 weeks </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Quadruple testing, also known as the quadruple screen or quad screen, is typically performed between 15-20 weeks of pregnancy, with the most accurate results obtained between 16-18 weeks. The test measures four serum analytes:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maternal serum alpha-fetoprotein (MSAFP)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Unconjugated estriol (uE3)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Free Beta-hCG</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibin-A</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This test helps assess the risk of certain chromosomal abnormalities such as Down syndrome (trisomy 21) and trisomy 18, as well as neural tube defects. The quad screen has a lower sensitivity compared to the first trimester combined screening (which includes nuchal translucency and dual marker screening), making it particularly useful for women who present for prenatal care later in pregnancy.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. 9-11 weeks</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This timeframe is generally used for first trimester screening tests, such as the combined screening, which includes nuchal translucency and the dual marker test (free &beta;-hCG and PAPP-A).</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. 12-14 weeks</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This period is also used for the combined first trimester screening but is not appropriate for the quad screen.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. 22-28 weeks</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This period is outside the recommended timeframe for the quad screen. Tests in this period are more focused on gestational diabetes screening and routine ultrasounds.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The quadruple test is performed between 15-20 weeks of pregnancy to screen for chromosomal abnormalities and neural tube defects.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/14/6.jpg\" style=\"font-family:Calibri,sans-serif; font-size:12pt; font-style:italic; height:320px; width:700px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Easy to remember</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In Down Syndrome, Beta hCG and Inhibin A are increases (B &ndash; Big; B in Beta hCG, B in Inhibin A)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">*King Edward Abdicated his throne so all levels are decreased</span></span></span></span></p>",
      "correct_choice_id": 22618,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5796,
      "choices": [
        {
          "id": 23155,
          "text": "<p><span style=\"font-size:12pt;\">Carcinoma vagina</span></p>"
        },
        {
          "id": 23156,
          "text": "<p><span style=\"font-size:12pt;\">Carcinoma vulva</span></p>"
        },
        {
          "id": 23157,
          "text": "<p><span style=\"font-size:12pt;\">Carcinoma cervix</span></p>"
        },
        {
          "id": 23158,
          "text": "<p><span style=\"font-size:12pt;\">Carcinoma endometrium</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Sentinel lymph node biopsy is most useful in which of the following gynecological malignancies?&nbsp;</span>(INICET MAY 2018)</p>",
      "unique_key": "Q5909415",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585175,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Carcinoma vulva</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Sentinel lymph node biopsy is particularly useful in the management of vulval carcinomas among gynecological malignancies. The technique helps in determining the extent of lymph node involvement and thereby reduces unnecessary lymph node dissections and their associated complications, such as lymphedema. Sentinel lymph node biopsy can effectively identify the first lymph node (sentinel node) that drains the primary tumor, which is likely to be the first site of metastasis.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Lymphatic Mapping and Sentinel Node Biopsy:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>Intraoperative Injection:</strong> Intradermal injection of blue dye around the tumor to map lymphatic drainage.</span></li><li><span style=\"font-size:12pt;\"><strong>Radioactive Tracer:</strong> Labeling tissues with a radioactive tracer and localizing with a hand-held detector.</span></li><li><span style=\"font-size:12pt;\"><strong>Lymphoscintigraphy:</strong> This imaging technique has a 100% detection rate for sentinel lymph nodes.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Utility in Other Malignancies:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Breast carcinoma</span></li><li><span style=\"font-size:12pt;\">Penile carcinoma</span></li><li><span style=\"font-size:12pt;\">Malignant melanoma</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Carcinoma vagina:</strong> Sentinel lymph node biopsy is less commonly used in vaginal cancer compared to vulvar cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Carcinoma cervix:</strong> While sentinel lymph node biopsy can be used, it is more established and routinely applied in vulvar cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Carcinoma endometrium:</strong> Sentinel lymph node biopsy is also useful but not as prominently used as in vulvar carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Sentinel lymph node biopsy is most useful in vulvar carcinoma among gynecological malignancies to reduce unnecessary lymph node dissection and its complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 608, DC Dutta’s Textbook of Gynecology 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23156,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21760,
      "choices": [
        {
          "id": 87004,
          "text": "<p><span style=\"font-size:12pt;\">9 – 11 weeks</span></p>"
        },
        {
          "id": 87005,
          "text": "<p><span style=\"font-size:12pt;\">4 – 6 weeks</span></p>"
        },
        {
          "id": 87006,
          "text": "<p><span style=\"font-size:12pt;\">12 – 16 weeks</span></p>"
        },
        {
          "id": 87007,
          "text": "<p><span style=\"font-size:12pt;\">16 – 20 weeks</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old man has chosen to undergo vasectomy. What advice will you give this patient regarding the use of contraception post-vasectomy?&nbsp;</span>(FMGE JANUARY 2023)</p>",
      "unique_key": "Q4754859",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585160,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) 12 – 16 weeks</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">After undergoing a vasectomy, it is important to understand that while the procedure is highly effective at preventing pregnancy, it is not immediately effective. Sperm can still be present in the reproductive system for some time following the surgery. Therefore, it is crucial to use an alternative form of contraception until a follow-up test confirms that there are no longer any viable sperm present. It is estimated that this sterilization technique is effective after about 3 months or 20 ejaculates to empty the stored semen. A semen analysis report confirming azoospermia is essential to confirm this.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">After a vasectomy, alternative contraception should be used until a semen analysis confirms azoospermia, usually around 12-16 weeks post-surgery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Dutta textbook of obstetrics page 32</strong></span></p>",
      "correct_choice_id": 87006,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56970,
      "choices": [
        {
          "id": 227269,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Radiologist</span></span></span></p>"
        },
        {
          "id": 227270,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Gynecologist</span></span></span></p>"
        },
        {
          "id": 227271,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Legal advisor</span></span></span></p>"
        },
        {
          "id": 227272,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pediatrician</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">All are the members of the medical board in MTP &gt; 24 weeks, except?&nbsp;</span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NEET PG 2024)</span></span></p>",
      "unique_key": "Q1305336",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585166,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Legal advisor</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For medical termination of pregnancy (MTP) after 24 weeks, especially in cases of substantial fetal anomalies, a medical board is constituted. This board typically includes specialists relevant to the condition and the required medical care. The standard members include: <strong>Radiologist, Gynecologist and Pediatrician. </strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A legal advisor is not a part of this medical board, as the board&#39;s purpose is to provide medical, not legal, expertise. The fourth member is often a specialist relevant to the detected anomaly rather than a legal professional.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Radiologist:</span></strong><span style=\"font-size:12.0pt\"> Included to assess fetal abnormalities through imaging and provide critical information about the anomaly.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Gynecologist:</span></strong><span style=\"font-size:12.0pt\"> A core member who handles the MTP procedure and provides obstetric and gynecological care.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Pediatrician:</span></strong><span style=\"font-size:12.0pt\"> Included to give an opinion on the implications of fetal anomalies and expected postnatal outcomes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In MTP cases beyond 24 weeks, the medical board consists of medical professionals such as radiologists, gynecologists, and pediatricians, but not legal advisors.</span></span></span></p>",
      "correct_choice_id": 227271,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5813,
      "choices": [
        {
          "id": 23222,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Twin to Twin Transfusion Syndrome</span></span></span></p>"
        },
        {
          "id": 23223,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Monochorionic diamniotic pregnancy</span></span></span></p>"
        },
        {
          "id": 23224,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Monochorionic monoamniotic pregnancy</span></span></span></p>"
        },
        {
          "id": 23225,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Dichorionic diamniotic pregnancy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify this condition?&nbsp;</span></span>(INICET NOV 2018)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/1_QSiuVik.jpg\" style=\"height:233px; width:250px\" /></span></span></span></p>",
      "unique_key": "Q5800499",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585184,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Monochorionic monoamniotic pregnancy</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The image shows a monochorionic monoamniotic placenta, characterized by a single placenta with two umbilical cords and no intervening membrane. Monochorionic monoamniotic twins share both a chorion and an amniotic sac. This type of twinning occurs when the inner cell mass divides between days 8 to 12 of gestation, after the formation of the trophoblast, leading to a monochorionic condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Monochorionic monoamniotic twin gestations have a high fetal death rate due to several complications:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Preterm birth</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Congenital anomalies</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low birth weight</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cord entanglement</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The best time for delivery of monochorionic monoamniotic twins is between 32-34 weeks via Caesarean section.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Twin to Twin Transfusion Syndrome:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a complication seen in monochorionic twin pregnancies. It involves a donor twin and a recipient twin. The donor twin is anemic, growth-restricted, and has oligohydramnios, while the recipient twin is polycythemic, has polyhydramnios, and suffers from circulatory overload.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Monochorionic diamniotic pregnancy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> In this type of pregnancy, there are two amniotic cavities and one chorion. This occurs when the inner cell mass divides between 4-7 days of gestation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Dichorionic diamniotic pregnancy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This pregnancy type involves two amniotic cavities and two chorions. It occurs when the inner cell mass divides between 0-3 days of gestation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Monochorionic monoamniotic pregnancies involve a single placenta with two umbilical cords and no intervening membrane, occurring when the inner cell mass divides between days 8 to 12 of gestation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Dutta&rsquo;s textbook of Obstetrics 8th edition pg 233-234, </span></strong></span></span></p>",
      "correct_choice_id": 23224,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47851,
      "choices": [
        {
          "id": 190999,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Self</span></span></span></span></p>"
        },
        {
          "id": 191000,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Partner</span></span></span></span></p>"
        },
        {
          "id": 191001,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parent</span></span></span></span></p>"
        },
        {
          "id": 191002,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Legal guardian</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Who will give permission for MTP for a woman who is mentally unsound? (FMGE JANUARY 2024)</span></span></span></span></p>",
      "unique_key": "Q1910320",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585202,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Legal guardian</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For a woman who is mentally unsound, the permission for Medical Termination of Pregnancy (MTP) cannot be given by herself due to her compromised mental state. The legal requirement is that the consent must come from her legal guardian. A legal guardian is an individual who has been legally appointed to care for and make decisions on behalf of the mentally unsound person. This guardian may be a parent or another individual assigned by the court, but the key requirement is that the guardian must have legal authority to make such decisions.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Self:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A mentally unsound woman is not legally capable of giving consent for MTP due to her compromised mental state.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Partner:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While a partner may be involved in the decision-making process, they do not have the legal authority to give permission for MTP unless they are also the legal guardian.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Parent:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Although a parent might be a legal guardian, simply being a parent does not automatically grant the authority. The person must be legally recognized as the guardian.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The legal guardian must give permission for MTP for a woman who is mentally unsound, ensuring that the decision is made in the best interest of the patient.</span></span></span></span></p>",
      "correct_choice_id": 191002,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6005,
      "choices": [
        {
          "id": 23990,
          "text": "<p><span style=\"font-size:12pt;\">Immunosuppression can be continued during pregnancy</span></p>"
        },
        {
          "id": 23991,
          "text": "<p><span style=\"font-size:12pt;\">Pregnancy to be planned once the disease has been quiescent for at least 6 months and there is no evidence of renal dysfunction</span></p>"
        },
        {
          "id": 23992,
          "text": "<p><span style=\"font-size:12pt;\">High dose corticosteroids for lupus flare in pregnancy is safe</span></p>"
        },
        {
          "id": 23993,
          "text": "<p><span style=\"font-size:12pt;\">Ecospirin, methotrexate, cyclophosphamide, corticosteroids, azathioprine are safe in pregnancy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following is not true about lupus nephritis in pregnancy?&nbsp;</span>(INICET MAY 2022)</p>",
      "unique_key": "Q3092800",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585211,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Ecospirin, methotrexate, cyclophosphamide, corticosteroids, azathioprine are safe in pregnancy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">SLE is a chronic autoimmune disorder involving the multisystem. It affects young women of childbearing age. The renal involvement of the disease can manifest in the form of active lupus nephritis or flare-ups during pregnancy.</span></li><li><span style=\"font-size:12pt;\">It can lead to preterm births, preeclampsia, and pregnancy loss while the infant can suffer from neonatal lupus and heart block.</span></li><li><span style=\"font-size:12pt;\">Management includes</span></li><li><span style=\"font-size:12pt;\">Preconceptionally counseling: Conception during a period of quiescence for at least 6 months determines a successful outcome. Stable remission of renal disease for at least 6 months before conception is recommended.</span></li><li><span style=\"font-size:12pt;\">Corticosteroids are useful during episodes of lupus flare and can be used safely in pregnancy.</span></li><li><span style=\"font-size:12pt;\">Immunosuppressants such as azathioprine can be continued during pregnancy. It may be used in case of severe SLE</span></li><li><span style=\"font-size:12pt;\">Hydroxychloroquine is found to be the best for maintenance and is safe in pregnancy. It can prevent the need for prolonged corticosteroid therapy.</span></li><li><span style=\"font-size:12pt;\">Methotrexate and cyclophosphamide are teratogenic and hence they are not safe during pregnancy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Immunosuppression can be continued during pregnancy</strong>: Correct. Medications like azathioprine can be continued under medical guidance, while others are used cautiously.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Pregnancy to be planned once the disease has been quiescent for at least 6 months and there is no evidence of renal dysfunction</strong>: Correct. Quiescence of the disease and stable renal function are crucial for a successful pregnancy outcome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. High dose corticosteroids for lupus flare in pregnancy is safe</strong>: Correct. High doses of corticosteroids can be used during a lupus flare, but must be carefully monitored.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Methotrexate and cyclophosphamide are not safe during pregnancy for managing lupus nephritis; corticosteroids and azathioprine are safer options.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page 2895, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23993,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5678,
      "choices": [
        {
          "id": 22684,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pubococcygeus</span></span></span></p>"
        },
        {
          "id": 22685,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bulbospongiosus</span></span></span></p>"
        },
        {
          "id": 22686,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ischiocavernosus </span></span></span></p>"
        },
        {
          "id": 22687,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Superficial transverse perineal</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The deepest part of perineal body injury, which causes cystocele, enterocoele and urethral descent is?&nbsp;(INICET MAY 2017)</span></span></p>",
      "unique_key": "Q6453522",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585179,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Pubococcygeus</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pubococcygeus is the deepest part of the levator ani muscle. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Injury to it can cause enterocele, cystocele, and urethral descent.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The levator ani muscles are the most important muscles in the pelvic floor and maintain a constant state of contraction. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Weakening of this muscle decreases support for the vagina, bladder, uterus, or rectum or alter the position of the neck of the bladder and urethra.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Bulbospongiosus, Option C. ischiocavernosus&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">and&nbsp;</span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. superficial transverse perineal</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> are all superficial muscles and their damage does not result in uterovaginal descent</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Supports of the vagal have been described by Delancey as shown below and defects in these lead to different levels of uterovaginal prolapse</span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Defect in Level 1 support: Vaginal apical prolapse and uterine prolapse</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Defect in level 2 support: Cystocele and Rectocele</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Defect in level 3 support: urethrocele and deficient perineal body</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/screenshot-2023-11-18-174103.jpg\" style=\"height:427px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 544, Williams Gynecology 3<sup>rd</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 22684,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56832,
      "choices": [
        {
          "id": 226721,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Do ultrasound for gestational age, check for abnormalities, check sex, and tell the mother.</span></span></span></p>"
        },
        {
          "id": 226722,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Do ultrasound for gestational age, check for abnormalities, check sex but don&rsquo;t tell the mother.</span></span></span></p>"
        },
        {
          "id": 226723,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Do ultrasound for gestational age, check for abnormalities, don&rsquo;t check the sex.</span></span></span></p>"
        },
        {
          "id": 226724,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Don&rsquo;t do ultrasound, do ANC only.</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old G5L4 with all 4-girl children presents at 18 weeks and asks for the sex of the child on ultrasound. This is her first antenatal visit. What should be done? (NEET PG 2024)</span></span></p>",
      "unique_key": "Q7138820",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585161,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Do ultrasound for gestational age, check for abnormalities, don&rsquo;t check the sex.</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The Ans<strong>.</strong> is C because, according to the Pre-Conception and Pre-Natal Diagnostic Techniques (PCPNDT) Act, sex determination of the fetus is illegal and punishable by law. At 18 weeks, the primary purpose of the ultrasound is to assess gestational age and check for any fetal abnormalities as part of the anomaly scan. Checking or revealing the sex of the fetus is prohibited and carries legal consequences. Therefore, the healthcare provider should perform the ultrasound for the medical purposes it is intended for and avoid even viewing the sex of the fetus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Do ultrasound for gestational age, check for abnormalities, check sex, and tell the mother:</strong> is incorrect because checking the sex and informing the mother is illegal under the PCPNDT Act, and can lead to legal repercussions, including imprisonment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Do ultrasound for gestational age, check for abnormalities, check sex but don&rsquo;t tell the mother:</strong> is also incorrect. Even looking at the fetus&rsquo;s sex, regardless of whether it is disclosed, is a violation of the law and is punishable.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Don&rsquo;t do ultrasound, do ANC only:</strong> is incorrect because the ultrasound at 18 weeks is necessary for evaluating gestational age and detecting any fetal abnormalities, which are critical aspects of prenatal care.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The key point to remember is that checking or revealing the sex of the fetus during an ultrasound is illegal under the PCPNDT Act. The ultrasound should only be used for assessing fetal gestational age and abnormalities.</span></span></p>",
      "correct_choice_id": 226723,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5829,
      "choices": [
        {
          "id": 23286,
          "text": "<p><span style=\"font-size:12pt;\">Male condom</span></p>"
        },
        {
          "id": 23287,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Female condom</span></p>"
        },
        {
          "id": 23288,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Diaphragm</span></p>"
        },
        {
          "id": 23289,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Cervical cap</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Identify the contraceptive shown in the given image:</span><span style=\"font-size:12.0pt;\"> (NEET PG 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/27/feamle-condom.jpg\" alt=\"\" width=\"300\" height=\"135\"></span></p>",
      "unique_key": "Q2576231",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585189,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Female condom</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The image is of a female condom.&nbsp;</span></li><li><span style=\"font-size:12pt;\">It is made of aa synthetic nitrile sheath with one flexible polyurethane ring at each end</span></li><li><span style=\"font-size:12pt;\">One ring is open – lies outside the vagina.</span></li><li><span style=\"font-size:12pt;\">The closed ring is fitted under the symphysis like a diaphragm</span></li><li><span style=\"font-size:12pt;\">Male condoms should not be used simultaneously due to friction leading to slippage of condom or tearing</span></li><li><span style=\"font-size:12pt;\">Also offers protection against STDs</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Male Condom:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/14/4.jpg\" alt=\"\" width=\"300\" height=\"200\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Cervical diaphragm:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/14/5.jpg\" alt=\"\" width=\"300\" height=\"248\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Cervical Cap:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/14/6_KwH3NWQ.jpg\" alt=\"\" width=\"300\" height=\"300\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The female condom is a synthetic nitrile sheath with one flexible polyurethane ring at each end, providing contraceptive protection and protection against STDs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page n 612, DC Dutta’s Textbook of Obstetrics, 8<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23287,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5847,
      "choices": [
        {
          "id": 23358,
          "text": "<p><span style=\"font-size:12pt;\">VIA</span></p>"
        },
        {
          "id": 23359,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿VILI</span></p>"
        },
        {
          "id": 23360,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿PAP smear</span></p>"
        },
        {
          "id": 23361,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Colposcopy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The following instrument is used for……:&nbsp;</span>&nbsp;(INICET MAY 2019)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/1_xZqzTuR.jpg\" alt=\"\" width=\"300\" height=\"51\"></span></p>",
      "unique_key": "Q2624712",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585194,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) PAP smear</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The image shown is that of Ayre's spatula which is used for preparing PAP smear.</span></li><li><span style=\"font-size:12pt;\">It is used to scrape the squamocolumnar junction of the cervix while preparing a Pap smear.</span></li><li><span style=\"font-size:12pt;\">A cytobrush is used to take endocervical samples</span></li><li><span style=\"font-size:12pt;\">The smear is fixed with 95% ethanol</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. VIA</strong>: This is Visual Inspection under Acetic Acid. This is done by applying acetic acid on the cervix. Any acetowhite area is suspicious for dysplasia. It is done in low resource settings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. VILI</strong>: Visual inspection under Lugol Iodine: This is done by applying Lugol’s iodine on the cervix. A dysplastic area will not take up iodine. It is also done in low resource settings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/03/screenshot-2024-08-03-175609.png\" alt=\"\" width=\"500\" height=\"440\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Colposcopy</strong>: This is a magnified view of the cervix. It is done in patients with abnormal pap smear/ HPV +Ve/ VIA +ve or VILI +ve.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Ayre's spatula is used for preparing a Pap smear by scraping cells from the cervix for cytological examination.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 325, DC Dutta’s Textbook of Gynecology 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23360,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ImageBased",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6119,
      "choices": [
        {
          "id": 24445,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vacuum-assisted delivery </span></span></span></p>"
        },
        {
          "id": 24446,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cesarean section </span></span></span></p>"
        },
        {
          "id": 24447,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal vaginal delivery </span></span></span></p>"
        },
        {
          "id": 24448,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Forceps delivery</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A primigravida presents to the emergency room in the early stage of labor with adequate uterine contractions. On per vaginal examination, a gynecoid pelvis is felt, the membranes are ruptured, and the vertex is felt in the right occipito-posterior position. How will you manage this patient?</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;</span></span>(NEET PG 2022)</p>",
      "unique_key": "Q6805440",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585200,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Normal vaginal delivery </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal vaginal delivery:</span></strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assuming the patient has no other complications, such as fetal distress or cephalopelvic disproportion, the given features of right occipito-posterior presentation with a favorable pelvis (gynecoid) and adequate uterine contractions can be managed by normal vaginal delivery.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In 90% of circumstances with a favorable pelvis and strong uterine contractions, without any complications, the occipito-posterior position can undergo the mechanism of normal labor.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient can be closely monitored for the progress of normal vaginal delivery. However, if complications arise or labor stalls, alternative methods such as vacuum-assisted delivery or forceps delivery may be considered. A cesarean section would only be necessary if there were complications that prevented a safe vaginal delivery.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Vacuum-assisted delivery:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vacuum-assisted delivery is generally considered when there is prolonged second stage of labor or fetal distress. In this case, since there are no complications mentioned and the pelvis is favorable, normal vaginal delivery is the preferred option.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Cesarean section:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A cesarean section is usually considered when there is cephalopelvic disproportion, fetal distress, or failure to progress in labor. Given the favorable conditions in this scenario, a normal vaginal delivery is feasible.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Forceps delivery:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Forceps delivery, like vacuum-assisted delivery, is used in cases of prolonged second stage of labor or when there is a need to expedite delivery. In the absence of such complications, normal vaginal delivery is the appropriate management.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Right occipito-posterior presentation with a favorable pelvis and adequate uterine contractions in a primigravida can be managed by closely monitoring for a normal vaginal delivery, provided there are no complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 89, Williams Obstetrics 26<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 24447,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55311,
      "choices": [
        {
          "id": 220705,
          "text": "<p><span style=\"font-size:12.0pt;\">12 weeks</span></p>"
        },
        {
          "id": 220706,
          "text": "<p><span style=\"font-size:12.0pt;\">20 weeks</span></p>"
        },
        {
          "id": 220707,
          "text": "<p><span style=\"font-size:12.0pt;\">24 weeks</span></p>"
        },
        {
          "id": 220708,
          "text": "<p><span style=\"font-size:12.0pt;\">No upper limit</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">MTP for failure of contraception can be done till: (FMGE JULY 2024)</span></p>",
      "unique_key": "Q8877432",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585169,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 20 weeks</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct answer is <strong>20 weeks</strong>. According to the Medical Termination of Pregnancy (MTP) Amendment Act of 2021, termination of pregnancy for the failure of contraception can be performed up to 20 weeks. The Act outlines specific requirements for performing an MTP at different stages of pregnancy:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Up to 20 weeks</strong>: MTP can be done for various reasons, including maternal health risks, fetal anomalies, pregnancy resulting from rape, or failure of contraception. <strong>Only one doctor's</strong> opinion is required for termination within this period.</span></li><li><span style=\"font-size:12.0pt;\"><strong>20 to 24 weeks</strong>: Requires the <strong>opinion of two doctors</strong>. The reasons include threats to maternal health, fetal anomalies, pregnancy resulting from rape, pregnancies in minors, changes in marital status (e.g., becoming a widow or divorce), humanitarian grounds (e.g., war, natural disasters), or if the woman is disabled.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Beyond 24 weeks</strong>: Termination is only permitted for substantial fetal malformations and requires approval from a <strong>medical board</strong> due to the viability of the fetus at this stage.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Under the MTP Amendment Act of 2021, MTP for failure of contraception can be performed up to <strong>20 weeks</strong> with the opinion of one doctor.</span></p>",
      "correct_choice_id": 220706,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5849,
      "choices": [
        {
          "id": 23366,
          "text": "<p><span style=\"font-size:12pt;\">Amniocentesis at 16 weeks</span></p>"
        },
        {
          "id": 23367,
          "text": "<p><span style=\"font-size:12pt;\">Manual removal of placenta</span></p>"
        },
        {
          "id": 23368,
          "text": "<p><span style=\"font-size:12pt;\">Intrauterine transfusion at 28 weeks</span></p>"
        },
        {
          "id": 23369,
          "text": "<p><span style=\"font-size:12pt;\">MTP at 63 days</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Anti-D vaccine is not given in which of the following conditions?&nbsp;</span>(INICET MAY 2019)</p>",
      "unique_key": "Q8374705",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585195,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Intrauterine transfusion at 28 weeks</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The Anti-D vaccine (anti-D immunoglobulin) is typically administered to prevent Rh sensitization in Rh-negative women who might be exposed to Rh-positive fetal blood. It is given to protect against the formation of anti-Rh antibodies that could affect future pregnancies. The vaccine is not given after an intrauterine transfusion because this procedure is performed to treat severe fetal anemia in cases where the mother is Rh-positive or the indirect Coombs test (ICT) is positive, indicating that the mother has already been sensitized.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Amniocentesis at 16 weeks:</strong> Anti-D vaccine is given after amniocentesis to prevent Rh sensitization, as the procedure can cause fetal blood to mix with maternal blood.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Manual removal of placenta:</strong> Anti-D vaccine is administered after manual removal of the placenta to prevent sensitization, as this procedure can result in significant feto-maternal hemorrhage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. MTP at 63 days:</strong> Anti-D vaccine is given after medical termination of pregnancy (MTP) to prevent Rh sensitization if the mother is Rh-negative and the fetus is Rh-positive.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Anti-D vaccine is not given after intrauterine transfusion, as this procedure is used to treat severe fetal anemia and does not require further prophylaxis against Rh sensitization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 919, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23368,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5881,
      "choices": [
        {
          "id": 23494,
          "text": "<p><span style=\"font-size:12pt;\">Cervical length</span></p>"
        },
        {
          "id": 23495,
          "text": "<p><span style=\"font-size:12pt;\">Type of maternal pelvis</span></p>"
        },
        {
          "id": 23496,
          "text": "<p><span style=\"font-size:12pt;\">Cervical position</span></p>"
        },
        {
          "id": 23497,
          "text": "<p><span style=\"font-size:12pt;\">Dilatation of cervix</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a component of the Bishop score?&nbsp;</span>(INICET MAY 2020)</p>",
      "unique_key": "Q4405097",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585213,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Type of maternal pelvis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Bishop Score</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">This is a scoring system used to assess the favorability of the cervix to respond to induction of labor.&nbsp;</span></li><li><span style=\"font-size:12pt;\">A cervix that is soft in consistency, a little dilated, short in length, anteriorly placed and the station of the presenting low down will respond well to induction of labor.&nbsp;</span></li><li><span style=\"font-size:12pt;\">The Bishop score was replaced by the Modified Bishop score, wherein, the cervical effacement (in terms of percentage) was replaced by cervical length (in cm).&nbsp;</span></li><li><span style=\"font-size:12pt;\">The 5 components of the Modified Bishop score are:</span><ol><li><span style=\"font-size:12pt;\">Cervical Dilatation</span></li><li><span style=\"font-size:12pt;\">Cervical length</span></li><li><span style=\"font-size:12pt;\">Cervical consistency</span></li><li><span style=\"font-size:12pt;\">Cervical Position</span></li><li><span style=\"font-size:12pt;\">Station of the presenting part</span></li></ol></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Easy to remember Mnemonic</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">B – Bishop</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">I – Effacement</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">S – Station of presenting part</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">H – Hard/ soft (consistency)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">O – Os dilatation (cervical dilatation)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">P – Position of the cervix</span><br>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The scoring is as shown in the table.</span></li><li><span style=\"font-size:12pt;\">Each component is scored from 0 to 3</span></li><li><span style=\"font-size:12pt;\">The highest score is 13 and the lowest is 0</span></li><li><span style=\"font-size:12pt;\">A favourable score is &gt; 6. This means the patient will respond favorably to methods of induction of labor.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/26/untitled-226.jpg\" alt=\"\" width=\"900\" height=\"473\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Cervical length</strong>: This is a component of the Modified Bishop score, measuring the length of the cervix in centimeters.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Cervical position</strong>: This is a component of the Bishop score, assessing the position of the cervix relative to the vaginal canal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Dilatation of cervix</strong>: This is a component of the Bishop score, measuring the extent to which the cervix has opened.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The Type of maternal pelvis is not a component of the Bishop score.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 600, DC Dutta’s Textbook of Obstetrics 8<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23495,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5900,
      "choices": [
        {
          "id": 23570,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometriosis</span></span></span></p>"
        },
        {
          "id": 23571,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adenomyosis</span></span></span></p>"
        },
        {
          "id": 23572,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Leiomyoma</span></span></span></p>"
        },
        {
          "id": 23573,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometrial hyperplasia</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman presented with a lower abdominal mass and lower abdominal discomfort. On examination, the uterus appears uniformly enlarged and adnexa is free. MRI shows the presence of a myometrial cyst. What is the most probable diagnosis?</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;</span></span>(NEET PG 2019)</p>",
      "unique_key": "Q5804087",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585167,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Adenomyosis </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adenomyosis is the presence of endometrial tissue in the myometrium. The uterus is generally uniformly enlarged up to 12-14 weeks size and can be tender on examination. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Investigation of choice: Ultrasound</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">On ultrasound, the following can be seen in adenomyosis:</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/14/untitled-70.jpg\" style=\"height:277px; width:400px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Management of adenomyosis</span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medical management: For symptomatic relief</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Total Hysterectomy (Definitive treatment - Treatment of choice if family is complete)</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Endometriosis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This presents as 5Ds (Dysmenorrhoea, Dyspareunia, Dyschezia, Dysfertility and Dull-aching abdominal pain). Diagnostic modality of choice is laparoscopy. Myometrial cysts are not seen. Endometriotic (chocolate) cysts in the ovary may be seen. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Leiomyoma</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Fibroids or leiomyomas usually present with menorrhagia and dysmenorrhoea. If very large, they will present with abdominal mass and pelvic pressure. On ultrasound, depending on the location, well circumscribed rounded lesions are seen. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Endometrial hyperplasia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This will present as menorrhagia. On ultrasound the endometrium will be thickened. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adenomyosis is characterized by a uniformly enlarged uterus with myometrial cysts, diagnosed primarily via ultrasound.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 196, DC Dutta&rsquo;s Textbook of Gynecology, 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23571,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5923,
      "choices": [
        {
          "id": 23662,
          "text": "<p><span style=\"font-size:12.0pt;\">&gt;92 mg/dL</span></p>"
        },
        {
          "id": 23663,
          "text": "<p><span style=\"font-size:12.0pt;\">&gt;95 mg/dL</span></p>"
        },
        {
          "id": 23664,
          "text": "<p><span style=\"font-size:12.0pt;\">&gt;106 mg/dL</span></p>"
        },
        {
          "id": 23665,
          "text": "<p><span style=\"font-size:12.0pt;\">&gt;90 mg/dL</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">According to IADPSG, what is the cut-off value of fasting blood glucose for the diagnosis of gestational diabetes mellitus?&nbsp;</span>(INICET MAY 2021)</p>",
      "unique_key": "Q2873248",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585178,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) &gt; 92 mg/dL</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The International Association of Diabetes and Pregnancy Study Groups (IADPSG) has established criteria for the diagnosis of gestational diabetes mellitus (GDM). According to their guidelines:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The fasting blood glucose cut-off value for diagnosing GDM during a 75g oral glucose tolerance test (OGTT) is <strong>&gt;92 mg/dL</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This value is used as part of a comprehensive assessment, including 1-hour and 2-hour postprandial glucose levels. The IADPSG criteria for GDM diagnosis include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Fasting:</strong> ≥92 mg/dL</span></li><li><span style=\"font-size:12.0pt;\"><strong>1-hour:</strong> ≥180 mg/dL</span></li><li><span style=\"font-size:12.0pt;\"><strong>2-hour:</strong> ≥153 mg/dL</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">If any one of these values is abnormal, the diagnosis of GDM can be made.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. &gt;95 mg/dL</strong>: This is not the IADPSG recommended cut-off for fasting blood glucose. It is higher than the specified cut-off value for diagnosing GDM.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. &gt;106 mg/dL</strong>: This value is significantly higher than the recommended cut-off. It exceeds the threshold for diagnosing GDM according to IADPSG guidelines.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. &gt;90 mg/dL</strong>: While this value is close, it is slightly below the IADPSG recommended cut-off of &gt;92 mg/dL for diagnosing GDM.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The cut-off value of fasting blood glucose for the diagnosis of gestational diabetes mellitus according to IADPSG is &gt;92 mg/dL.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Page no 326, DC Dutta’s Textbook of Obstetrics 8<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23662,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54773,
      "choices": [
        {
          "id": 218557,
          "text": "<p><span style=\"font-size:12.0pt;\">Labetalol + MgSO4 + Expedite delivery</span></p>"
        },
        {
          "id": 218558,
          "text": "<p><span style=\"font-size:12.0pt;\">Labetalol + MgSO4 + Wait till 37 weeks</span></p>"
        },
        {
          "id": 218559,
          "text": "<p><span style=\"font-size:12.0pt;\">Labetalol + Corticosteroids + wait till 37 weeks</span></p>"
        },
        {
          "id": 218560,
          "text": "<p><span style=\"font-size:12.0pt;\">Labetalol + Corticosteroids + Expedite delivery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents at 36 weeks with chronic HTN and 3+ proteinuria. Her BP is 170/100 mmHg and she complains of headache and blurring of vision. What is the best management option? (INICET MAY 2024)</span></p>",
      "unique_key": "Q7599765",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585209,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Labetalol + MgSO4 + Expedite delivery</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This patient is presenting with chronic hypertension that has progressed to superimposed preeclampsia, indicated by the development of 3+ proteinuria, a blood pressure of 170/100 mmHg, and symptoms such as headache and blurring of vision. These symptoms and her elevated blood pressure suggest severe preeclampsia.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Severe Preeclampsia</strong>: A systolic blood pressure greater than 160 mmHg or a diastolic blood pressure greater than 110 mmHg, along with symptoms like headache and visual disturbances, are indicators of severe preeclampsia. In this case, the patient’s condition requires urgent management to prevent the development of eclampsia, a condition that can lead to seizures and other severe complications.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Management</strong>: The correct management for severe preeclampsia at 36 weeks gestation includes the administration of <strong>Labetalol</strong> to lower the blood pressure, <strong>Magnesium sulfate (MgSO4)</strong> to prevent seizures, and <strong>expedited delivery</strong> to resolve the preeclampsia. After 34 weeks of gestation, delivery is recommended for severe preeclampsia because the risks of continuing the pregnancy outweigh the benefits.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;Labetalol + MgSO4 + Wait till 37 weeks: </strong>As this is severe preeclampsia, there is a very high risk waiting till 37 weeks. Immediate delivery is indicated after 34 weeks</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.&nbsp;Labetalol + Corticosteroids + wait till 37 weeks: </strong>There is no indication for corticosteroids as she has crossed 34 weeks and also there is no indication to wait till 37 weeks as this is severe preeclampsia</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Labetalol + Corticosteroids + Expedite delivery:&nbsp;</strong>Although delivery needs to be expedited, there is no indication for corticosteroids as she has crossed 34 weeks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In cases of severe preeclampsia after 34 weeks, immediate delivery, blood pressure control with labetalol, and seizure prophylaxis with magnesium sulfate are essential for optimal maternal and fetal outcomes.</span></p>",
      "correct_choice_id": 218557,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5979,
      "choices": [
        {
          "id": 23886,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Measure CA 125 levels</span></span></span></p>"
        },
        {
          "id": 23887,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follow up after 6 weeks</span></span></span></p>"
        },
        {
          "id": 23888,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Laparoscopy</span></span></span></p>"
        },
        {
          "id": 23889,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CT pelvis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 26-year-old woman who has had 2 children through normal delivery presents with a dull aching pain over the abdomen, with irregular menses. Per vaginal examination revealed a mass felt through the posterior fornix. A USG showed a clear ovarian cyst of size 5 x 5 cm. What is the next best step?&nbsp;</span></span>(INICET NOV 2021)</p>",
      "unique_key": "Q8279405",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585197,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Follow up after 6 weeks</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A clear ovarian cyst with minimal symptoms and size less than 8 cm in a woman of reproductive age group is most likely a functional ovarian cyst. The next best step in the management of this case is to follow up after 6-12 weeks and perform a repeat USG.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Key Points:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Functional Ovarian Cyst:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> In reproductive-aged women, a clear ovarian cyst less than 8 cm is likely functional.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follow-Up:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The recommended management is to follow up after 6-12 weeks with a repeat ultrasound to check if the cyst resolves on its own.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Indications for Further Intervention:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Surgical treatment is warranted if there are worrying features, the cyst is greater than 8 cm, there are significant symptoms, or CA-125 levels are raised.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Measure CA 125 levels:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> CA 125 is a marker for epithelial ovarian tumors and is more relevant in postmenopausal women. It has limited role in premenopausal women with clear, simple cysts.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Laparoscopy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Surgical intervention such as laparoscopy is not immediately necessary for a 5 cm cyst unless there are concerning features or persistence after follow-up.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. CT pelvis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> CT scan is not typically indicated for initial assessment of a simple ovarian cyst detected on ultrasound.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Additional information:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">OC Pills:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Oral contraceptive pills have not been proven effective in treating simple ovarian cysts, though they are often used.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Simple Ovarian Cysts:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Any simple ovarian cyst less than 5 cm without symptoms can be left alone.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For a reproductive-aged woman with a clear ovarian cyst less than 8 cm and minimal symptoms, the best approach is to follow up with a repeat ultrasound after 6-12 weeks, rather than immediate intervention.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: RCOG greentop guideline number 62 , Williams textbook of gynecology 3<sup>rd</sup> edition pg217</span></strong></span></span></p>",
      "correct_choice_id": 23887,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56833,
      "choices": [
        {
          "id": 226725,
          "text": "<p><span style=\"font-size:12.0pt;\">MTP cannot be done as she has crossed 20 weeks</span></p>"
        },
        {
          "id": 226726,
          "text": "<p><span style=\"font-size:12.0pt;\">MTP can be done till 24 weeks</span></p>"
        },
        {
          "id": 226727,
          "text": "<p><span style=\"font-size:12.0pt;\">MTP can be done only if the mother's life is at risk</span></p>"
        },
        {
          "id": 226728,
          "text": "<p><span style=\"font-size:12.0pt;\">MTP can only be done if there is a substantial fetal anomaly</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 14-year-old girl, a victim of rape, presents at 22 weeks for abortion. What advice will you give her? (NEET PG 2024)</span></p>",
      "unique_key": "Q1282968",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585158,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>&nbsp;Ans.&nbsp; B)&nbsp; MTP can be done till 24 weeks</strong></span></p><p><span style=\"font-size:11pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">The MTP Act of 2021 in India allows for abortions b/w 20- 24 weeks in specific cases, including:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Rape or sexual assault:</strong> The girl in the question is a victim of rape, which falls under this category.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Risk to maternal life or Disability:</strong> If continuing the pregnancy poses a significant risk to the mother's health or life.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Substantial fetal anomaly:</strong> If the fetus has severe abnormalities incompatible with life or causing significant disability.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Minors:</strong> The girl is 14 years old, making her a minor, and the law provides special considerations for them.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Change in marital status or humanitarian grounds:</strong> These are additional situations where MTP may be considered up to 24 weeks.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. MTP cannot be done as she has crossed 20 weeks:</strong> This is incorrect. While the general limit for MTP is 20 weeks, certain circumstances, like rape, allow for MTP up to 24 weeks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. MTP can be done only if the mother's life is at risk:</strong> This is partially correct. While risk to the mother's life is a valid reason, it's not the only one. Rape is also a valid indication for MTP up to 24 weeks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. MTP can only be done if there is a substantial fetal anomaly:</strong> Again, this is partially correct. Substantial fetal anomaly is one reason, but rape is another valid reason for MTP up to 24 weeks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>In India, under the MTP Act of 2021:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/12/screenshot-2024-09-12-121328.jpg\" alt=\"\" width=\"800\" height=\"746\"></strong></span></p>",
      "correct_choice_id": 226726,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5735,
      "choices": [
        {
          "id": 22912,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The quantity of sperms</span></span></span></p>"
        },
        {
          "id": 22913,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The motility of sperms</span></span></span></p>"
        },
        {
          "id": 22914,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The morphology of sperms</span></span></span></p>"
        },
        {
          "id": 22915,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The number of sperm</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the best parameter to assess in case of male infertility?&nbsp;</span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(AIIMS NOV 2017)</span></span></span></span></p>",
      "unique_key": "Q7035677",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585199,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) The morphology of sperms</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The morphology of sperms is considered the best parameter to assess male infertility. Sperm morphology refers to the size and shape of sperm, and abnormalities in these characteristics can significantly affect a man&#39;s fertility.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Key Points:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sperm Morphology:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Characterization of normal sperm morphology shows improved correlation with fertilization rates during IVF cycles. A significantly decreased fertilization rate is observed when the normal morphology of the sample falls below the strict criteria of 4%.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sperm Quantity and Number:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While the quantity and number of sperms are important, they are not as critical as morphology in determining fertility potential.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sperm Motility:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Motility is also a crucial factor, but morphology has a stronger correlation with fertilization success.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. The quantity of sperms:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Refers to the total volume of ejaculate, which is less indicative of fertility compared to morphology.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. The motility of sperms:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Important for fertility but not as strongly correlated with fertilization success as morphology.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. The number of sperm:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Similar to the quantity, the number is important but does not correlate as closely with fertilization rates as morphology does.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sperm morphology is the most significant parameter for assessing male infertility, as it closely correlates with fertilization rates during assisted reproductive techniques like IVF.</span></span></span></p>",
      "correct_choice_id": 22914,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5959,
      "choices": [
        {
          "id": 23806,
          "text": "<p><span style=\"font-size:12pt;\">Methotrexate with folinic acid</span></p>"
        },
        {
          "id": 23807,
          "text": "<p><span style=\"font-size:12pt;\">Methotrexate</span></p>"
        },
        {
          "id": 23808,
          "text": "<p><span style=\"font-size:12pt;\">EMACO regimen</span></p>"
        },
        {
          "id": 23809,
          "text": "<p><span style=\"font-size:12pt;\">Hysterectomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman who underwent dilatation and curettage for molar pregnancy 6 months ago presents with persistent symptoms of abdominal pain and distention. On further evaluation, the beta- hCG levels were persistently elevated and cannonball foci were found on the chest X-ray. What is the appropriate management in this case? (NEET PG 2021)</span></p>",
      "unique_key": "Q1012895",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585191,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Methotrexate with folinic acid</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Methotrexate with folinic acid:</strong> This is a clear case of post-molar choriocarcinoma with lung metastases. Treatment is based on prognostication and staging. According to the given scoring system, the parameters such as the time interval since the antecedent pregnancy, beta-hCG levels, and the presence of lung metastases suggest a low-risk choriocarcinoma. For low-risk choriocarcinoma, the recommended treatment is multi-dose single-agent chemotherapy with methotrexate. Methotrexate is administered in a multi-dose regimen (Day 1, 3, 5, 7) alternating with folinic acid (Day 2, 4, 6, 8).</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/15/1.jpg\" alt=\"\" width=\"1000\" height=\"643\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">&lt; 6: LOW RISK</span></li><li><span style=\"font-size:12pt;\">&gt; 7 HIGH RISK</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Methotrexate:</strong> Methotrexate alone might be considered for very low-risk cases. However, in this case, with persistent elevated beta-hCG levels and lung metastases, a multi-dose regimen along with folinic acid is preferred to enhance efficacy and reduce toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. EMACO regimen:</strong> The EMACO regimen, which includes etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine, is used for high-risk choriocarcinoma. This patient's score indicates a low-risk profile, making EMACO unnecessary and more toxic than needed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Hysterectomy:</strong> Hysterectomy is not the first line of treatment for choriocarcinoma, especially in the context of low-risk metastatic disease. It may be considered in cases of heavy bleeding or when the disease is confined to the uterus and chemotherapy is not effective.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Low-risk choriocarcinoma post-molar pregnancy with lung metastases is treated with a multi-dose regimen of methotrexate alternating with folinic acid</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page 789, Williams Gynecology, 3<sup>rd</sup> edition</strong></span></p>",
      "correct_choice_id": 23806,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5708,
      "choices": [
        {
          "id": 22804,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Doxycycline</span></span></span></p>"
        },
        {
          "id": 22805,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amoxicillin</span></span></span></p>"
        },
        {
          "id": 22806,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fluconazole</span></span></span></p>"
        },
        {
          "id": 22807,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metronidazole</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old female came with complaints of greenish discharge per vagina and on examination she had a strawberry cervix. Which of the following is the treatment for her?&nbsp;(INICET MAY 2017)</span></span></p>",
      "unique_key": "Q8044187",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585193,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Metronidazole</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical presentation of greenish-yellow discharge and a strawberry cervix is characteristic of trichomoniasis. Trichomoniasis is a sexually transmitted infection caused by the protozoan Trichomonas vaginalis. The diagnostic feature of trichomoniasis includes the presence of motile flagellate organisms on a wet mount microscopy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Characteristic findings:</span></strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Colour of discharge:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Greenish yellow</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">On examination:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Strawberry cervix and vagina</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">pH:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> &gt;5</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diagnosis (Wet mount):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Motile flagellate organism</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The recommended treatment for trichomoniasis is metronidazole. It can be administered as a single dose of 2g or 200mg TDS for 7 days.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Doxycycline:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This antibiotic is used to treat various bacterial infections, including some sexually transmitted infections, but it is not the treatment of choice for trichomoniasis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Amoxicillin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This antibiotic is used for bacterial infections but is not effective against trichomoniasis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Fluconazole:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This antifungal medication is used to treat candidiasis, not trichomoniasis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Strawberry cervix and greenish-yellow vaginal discharge are characteristic of trichomoniasis, which is treated with metronidazole.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/03/screenshot-2024-08-03-154323.png\" style=\"height:447px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Strawberry cervix and vagina are characteristic of Trichomoniasis</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 164, DC Dutta&rsquo;s Textbook of Gynecology 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 22807,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47850,
      "choices": [
        {
          "id": 190995,
          "text": "<p><span style=\"font-size:12.0pt;\">It can be done with the opinion of 2 doctors</span></p>"
        },
        {
          "id": 190996,
          "text": "<p><span style=\"font-size:12.0pt;\">It cannot be done if there is a fetal Anomaly</span></p>"
        },
        {
          "id": 190997,
          "text": "<p><span style=\"font-size:12.0pt;\">It requires the opinion of a medical board</span></p>"
        },
        {
          "id": 190998,
          "text": "<p><span style=\"font-size:12.0pt;\">It cannot be done</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents at 22 weeks for an MTP due to failure of contraception. Which of the following is correct?&nbsp;(FMGE JANUARY 2024)</span></p>",
      "unique_key": "Q8580401",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585201,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) It cannot be done</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">As per the Medical Termination of Pregnancy (MTP) Amendment Act of 2021, the upper limit for termination due to failure of contraception is 20 weeks.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The Act extends the permissible gestational age for termination to 24 weeks, but only in specific cases, including:</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Fetal anomalies</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Pregnancies resulting from rape or sexual assault</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Maternal health risks</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Certain socio-economic conditions (e.g., a woman becoming a widow or getting divorced after conception)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In this case, the patient requests MTP at 22 weeks due to failure of contraception, which is not a legally permissible indication beyond 20 weeks.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">MTP beyond 20 weeks is only allowed for fetal anomalies and other specific conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. It can be done with the opinion of 2 doctors:</strong> Incorrect because MTP beyond 20 weeks for failure of contraception is not allowed, regardless of the number of doctors.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. It cannot be done if there is a fetal anomaly:&nbsp;</strong>Incorrect because MTP can be done up to 24 weeks in the presence of substantial fetal anomalies, with a board’s approval.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. It requires the opinion of a medical board</strong>: Incorrect because a medical board is only required for MTP beyond 24 weeks for fetal anomalies or rare medical conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">MTP for failure of contraception is only allowed up to 20 weeks.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">MTP between 20-24 weeks is permitted for specific cases such as fetal anomalies, maternal health risks, and pregnancies due to sexual assault.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Beyond 24 weeks, termination requires the approval of a medical board for severe fetal anomalies.</span></p>",
      "correct_choice_id": 190998,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23221,
      "choices": [
        {
          "id": 92848,
          "text": "<p><span style=\"font-size:12pt;\">Anovulation</span></p>"
        },
        {
          "id": 92849,
          "text": "<p><span style=\"font-size:12pt;\">Endometriosis</span></p>"
        },
        {
          "id": 92850,
          "text": "<p><span style=\"font-size:12pt;\">Malignancy</span></p>"
        },
        {
          "id": 92851,
          "text": "<p><span style=\"font-size:12pt;\">Bleeding disorder</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the most common cause of puberty menorrhagia?&nbsp;</span>(INICET MAY 2023)</p>",
      "unique_key": "Q3244151",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585181,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Anovulation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Anovulation is the most common cause of puberty menorrhagia. Menorrhagia refers to heavy menstrual bleeding that occurs in a regular cycle. In adolescents, anovulation, which is the failure of the ovary to release an oocyte during a menstrual cycle, frequently leads to heavy or prolonged bleeding due to the lack of a normal hormonal cycle that regulates the endometrial lining. Without the usual cyclical hormonal fluctuations, the endometrial lining may become excessively thick, leading to heavy bleeding when it sheds. This condition is typical in puberty due to the body's ongoing adjustment to hormonal regulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Endometriosis</strong>: Endometriosis involves the presence of endometrial tissue outside the uterus, which can cause painful menstruation and potentially contribute to menorrhagia. However, it is less common than anovulation as the primary cause of menorrhagia in adolescents.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Malignancy</strong>: Malignancy is a rare cause of menorrhagia in puberty. While malignancy can lead to abnormal bleeding, it is not the most common cause in this age group.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Bleeding disorder</strong>: Bleeding disorders such as von Willebrand disease or hemophilia can cause menorrhagia but are less common compared to anovulation in adolescents.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Anovulation is the most common cause of menorrhagia in puberty.</span></p>",
      "correct_choice_id": 92848,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5659,
      "choices": [
        {
          "id": 22608,
          "text": "<p><span style=\"font-size:12.0pt;\">Round ligament</span></p>"
        },
        {
          "id": 22609,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardinal ligament</span></p>"
        },
        {
          "id": 22610,
          "text": "<p><span style=\"font-size:12.0pt;\">Uterosacral ligament</span></p>"
        },
        {
          "id": 22611,
          "text": "<p><span style=\"font-size:12.0pt;\">Pubocervical ligament</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The ligament that maintains anteversion of the uterus during pregnancy is:</span> <span style=\"font-size:12.0pt;\">(NEET PG 2018)</span></p>",
      "unique_key": "Q4796252",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585170,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Round ligament</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The round ligament is responsible for maintaining the anteversion of the uterus, particularly during pregnancy. It consists of smooth muscle extensions of the uterine corpus and is the homologue of the gubernaculum testis. These ligaments arise from the lateral aspect of the corpus just below and anterior to the origin of the fallopian tubes, extend laterally to the pelvic sidewall, and enter the retroperitoneal space. They pass lateral to the inferior epigastric vessels before entering the inguinal canal through the internal inguinal ring and terminate in the subcutaneous tissue of the labia majora. During pregnancy, the round ligaments stretch to accommodate the enlarging uterus, helping to maintain its anteverted position. It maintains the angle of anteversion of 120°</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_mBEupkl.png\" width=\"567\" height=\"308\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Cardinal ligament</strong>: Also known as the transverse cervical ligament or Mackenrodt ligaments, these provide significant support to the uterus and cervix by attaching the lateral aspect of the uterus and cervix to the pelvic walls. However, they do not maintain anteversion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Uterosacral ligament</strong>: These ligaments insert broadly into the posterior pelvic walls and sacrum and form the lateral boundaries of the cul-de-sac (Pouch of Douglas). They play a role in supporting the uterus but do not contribute to maintaining anteversion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Pubocervical ligament</strong>: This ligament forms part of the supportive structure for the uterus and vagina, attaching them to the pubic bone. It provides anterior support but does not maintain the anteversion of the uterus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The round ligament is primarily responsible for maintaining the anteversion of the uterus, especially during pregnancy.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/15/12.jpg\" alt=\"\" width=\"815\" height=\"671\"></p>",
      "correct_choice_id": 22608,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5898,
      "choices": [
        {
          "id": 23562,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Declare as complete abortion and follow-up in 15 days</span></span></span></p>"
        },
        {
          "id": 23563,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Admit and observe</span></span></span></p>"
        },
        {
          "id": 23564,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diagnostic laparoscopy</span></span></span></p>"
        },
        {
          "id": 23565,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follow-up with beta-HCG</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with 6 weeks amenorrhea and a positive pregnancy test came with complaints of lower abdominal pain, moderate bleeding PV. She was hemodynamically stable. On ultrasound, there was no gestational sac in the uterus. Ovaries were normal and no free fluid in the pouch of Douglas. What is the next line of management?&nbsp;</span></span></span>(INICET NOV 2020)</p>",
      "unique_key": "Q4621660",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585165,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Follow-up with beta-HCG</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient presents with symptoms that could indicate either an ectopic pregnancy or an early miscarriage. The absence of a gestational sac in the uterus on ultrasound at 6 weeks&#39; gestation warrants further investigation to determine the location and viability of the pregnancy. The most appropriate next step is to follow up with serial beta-HCG levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Key Points:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ectopic Pregnancy vs. Early Miscarriage:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The differential diagnosis includes both ectopic pregnancy and early miscarriage.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serial Beta-HCG Measurement:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Beta-HCG levels typically double every 48-72 hours in a normal early intrauterine pregnancy. An abnormal rise or plateau in beta-HCG levels may indicate an ectopic pregnancy or a failing pregnancy.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ultrasound Follow-up:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> In combination with beta-HCG monitoring, follow-up ultrasounds can help determine if a gestational sac becomes visible in the uterus or elsewhere.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Declare as complete abortion and follow-up in 15 days:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Declaring a complete abortion without further investigation is premature and may miss an ectopic pregnancy, which can have serious complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Admit and observe:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While observation is important, serial beta-HCG levels provide critical information that can guide further management decisions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Diagnostic laparoscopy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is an invasive procedure and is not the first step in stable patients without definitive evidence of ectopic pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For a patient with 6 weeks of amenorrhea, a positive pregnancy test, and no gestational sac visible on ultrasound, the next step is to follow up with serial beta-HCG levels to differentiate between an early intrauterine pregnancy, an ectopic pregnancy, and a miscarriage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Williams Textbook of obstetrics 24<sup>th </sup>edition pg 356</span></strong></span></span></p>",
      "correct_choice_id": 23565,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44016,
      "choices": [
        {
          "id": 175723,
          "text": "<p><span style=\"font-size:12pt;\">Do UPT and then give DMPA</span></p>"
        },
        {
          "id": 175724,
          "text": "<p><span style=\"font-size:12pt;\">DMPA + 7 days backup</span></p>"
        },
        {
          "id": 175725,
          "text": "<p><span style=\"font-size:12pt;\">DMPA from next cycle</span></p>"
        },
        {
          "id": 175726,
          "text": "<p><span style=\"font-size:12pt;\">Give DMPA, no backup required</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A female patient taking DMPA came 14 days late. What should be advised to her?&nbsp;</span>(INICET NOV 2023)</p>",
      "unique_key": "Q7562248",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585206,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Give DMPA, no backup required</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">When a patient is up to 15 days late for a Depo-Provera (DMPA) injection, it is generally safe to administer the injection without additional contraceptive backup.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Do UPT and then give DMPA:</strong> Pregnancy testing is typically not required unless the delay exceeds 15 days.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. DMPA + 7 days backup:</strong> Backup contraception is recommended if the delay exceeds 15 days.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. DMPA from next cycle:</strong> There is no need to wait until the next cycle if the delay is within 15 days.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For patients receiving DMPA who are less than 15 days late for their injection, it can be administered without the need for additional contraceptive measures or delay.</span></p>",
      "correct_choice_id": 175726,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Controversial",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6074,
      "choices": [
        {
          "id": 24265,
          "text": "<p><span style=\"font-size:12pt;\">Mifepristone + misoprostol</span></p>"
        },
        {
          "id": 24266,
          "text": "<p><span style=\"font-size:12pt;\">Manual vacuum aspiration</span></p>"
        },
        {
          "id": 24267,
          "text": "<p><span style=\"font-size:12pt;\">Dilatation and evacuation</span></p>"
        },
        {
          "id": 24268,
          "text": "<p><span style=\"font-size:12pt;\">Extra-amniotic instillation of ethacridine lactate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following can be used in first-trimester medical termination of pregnancy (MTP), except:&nbsp;</span>(INICET NOV 2022)</p>",
      "unique_key": "Q2151200",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585186,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Extra-amniotic instillation of ethacridine lactate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Extra-amniotic instillation of ethacridine lactate</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">This method is typically used for second-trimester abortions. It involves the instillation of ethacridine lactate into the extra-amniotic space to induce abortion. However, it is rarely used nowadays due to advancements in other safer and more effective methods.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Medical methods of first-trimester abortion</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>Mifepristone + misoprostol</strong>: A combination of mifepristone (a progesterone receptor antagonist) and misoprostol (a prostaglandin analog) is a common and effective method for first-trimester medical termination of pregnancy.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Surgical methods of first-trimester abortion</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>Manual vacuum aspiration</strong>: This is a safe and effective method for terminating a pregnancy in the first trimester.</span></li><li><span style=\"font-size:12pt;\"><strong>Dilatation and curettage</strong>: Another surgical method used to evacuate the contents of the uterus in the first trimester.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Mifepristone + misoprostol</strong>: Mifepristone + misoprostol is a commonly used combination for medical termination in the first trimester.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Manual vacuum aspiration</strong>: Manual vacuum aspiration is a standard procedure for first-trimester abortion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Dilatation and evacuation</strong>: Dilatation and evacuation is another method used in the first trimester to terminate a pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Extra-amniotic instillation of ethacridine lactate is not used for first-trimester medical termination of pregnancy (MTP).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of obstetrics 24<sup>th</sup> edition pg364,369, Dutta’s textbook of obstetrics 8<sup>th</sup> edition pg203</strong></span></p>",
      "correct_choice_id": 24268,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21764,
      "choices": [
        {
          "id": 87020,
          "text": "<p><span style=\"font-size:16px;\">Improve treatment</span></p>"
        },
        {
          "id": 87021,
          "text": "<p><span style=\"font-size:16px;\">Fetal death rate analysis</span></p>"
        },
        {
          "id": 87022,
          "text": "<p><span style=\"font-size:16px;\">Improving hospital administration</span></p>"
        },
        {
          "id": 87023,
          "text": "<p><span style=\"font-size:16px;\">Done before analysing outcomes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which of the following statements is false regarding audit in obstetrics? (FMGE JANUARY 2023)</span></p>",
      "unique_key": "Q8059902",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585162,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) Done before analysing outcomes</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Clinical audit in obstetrics is a method performed to ensure that healthcare provisions are standardized and consistently improved in line with evidence-based practice. The purpose of an obstetrics audit is to analyze the current level of care and identify areas for improvement. Therefore, it is typically conducted after analyzing outcomes to assess and enhance the quality of care provided. This helps in determining whether the current practices are effective or if changes are needed to improve patient outcomes.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Improve treatment:&nbsp;</strong>This statement is true as clinical audits aim to improve treatment by identifying gaps in current practices and implementing evidence-based solutions to enhance patient care.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Fetal death rate analysis:&nbsp;</strong>This is also true. Clinical audits often include analyzing fetal death rates to understand the causes and contributing factors, which can lead to improved strategies to reduce such occurrences.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Improving hospital administration:&nbsp;</strong>This statement is correct. Audits can identify administrative issues that affect patient care, thereby helping to streamline processes and improve overall hospital administration and efficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Clinical audits in obstetrics are conducted after analyzing outcomes to ensure that healthcare provisions are standardized and continuously improved based on evidence-based practices.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ref: Dutta textbook of Obstetrics page728-729</strong></span></p>",
      "correct_choice_id": 87023,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5977,
      "choices": [
        {
          "id": 23878,
          "text": "<p><span style=\"font-size:12pt;\">Clomiphene citrate</span></p>"
        },
        {
          "id": 23879,
          "text": "<p><span style=\"font-size:12pt;\">Metformin</span></p>"
        },
        {
          "id": 23880,
          "text": "<p><span style=\"font-size:12pt;\">Tamoxifen</span></p>"
        },
        {
          "id": 23881,
          "text": "<p><span style=\"font-size:12pt;\">OCP</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not used to treat PCOD?&nbsp;</span>(INICET NOV 2021)</p>",
      "unique_key": "Q1648191",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585196,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Tamoxifen</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Tamoxifen is not commonly used in the treatment of Polycystic Ovary Disease (PCOD). Tamoxifen is a selective estrogen receptor modulator (SERM) primarily used in the treatment and prevention of breast cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Key Points:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Medical Management of PCOD:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>OCP (Option D):</strong> Oral contraceptive pills regulate the menstrual cycle and hormones and are given to women who are not desirous of fertility to regularize their cycles.</span></li><li><span style=\"font-size:12pt;\"><strong>Metformin (Option B):</strong> Metformin is an insulin sensitizer, which decreases hyperinsulinemia and improves fertility in patients with PCOD.</span></li><li><span style=\"font-size:12pt;\"><strong>Ovulation Induction Drugs:</strong></span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12pt;\"><strong>Clomiphene (Option A):</strong> Clomiphene citrate is commonly used to induce ovulation in women with infertility due to PCOD.</span></li><li><span style=\"font-size:12pt;\"><strong>Letrozole:</strong> Letrozole, an aromatase inhibitor, is the drug of choice for ovulation induction in PCOD.</span></li></ul></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Clomiphene citrate:</strong> Clomiphene is an ovulation induction agent used in the treatment of infertility in women with PCOD.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Metformin:</strong> Metformin is used to decrease insulin resistance and hyperinsulinemia in PCOD, which can help in regulating menstrual cycles and improving fertility.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. OCP:</strong> Oral contraceptive pills are used to regulate menstrual cycles and manage hormonal imbalances in women with PCOD who do not seek to become pregnant.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Tamoxifen is not typically used in the treatment of PCOD. Instead, treatments include oral contraceptive pills, metformin, and ovulation induction agents such as clomiphene and letrozole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of Gynecology 3rd edition. Pg 398 Dutta’s textbook of Gynecology 6<sup>th</sup> edition pg470</strong></span></p>",
      "correct_choice_id": 23880,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6006,
      "choices": [
        {
          "id": 23994,
          "text": "<p><span style=\"font-size:12pt;\">Elective C-section has no role in reducing incidence of brachial plexus injury</span></p>"
        },
        {
          "id": 23995,
          "text": "<p><span style=\"font-size:12pt;\">In a patient being planned for induction of labor, night dose of intermediate insulin is given as planned, and the morning dose is withheld</span></p>"
        },
        {
          "id": 23996,
          "text": "<p><span style=\"font-size:12pt;\">In active labor, if RBS &lt;70 mg%, D5 is started at 100-150 ml/h till the RBS is &gt;100 mg%</span></p>"
        },
        {
          "id": 23997,
          "text": "<p><span style=\"font-size:12pt;\">Capillary blood glucose monitoring levels are kept at fasting- 95 mg%; 1 h postprandial- 140 mg%; 2 h postprandial: 120 mg%</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is false regarding management of diabetes in pregnancy?&nbsp;</span>(INICET MAY 2022)</p>",
      "unique_key": "Q6509098",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585210,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Elective C-section has no role in reducing incidence of brachial plexus injury</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">False statement regarding management of diabetes in pregnancy is option A.</span></li><li><span style=\"font-size:12pt;\">The Cesarean section is found to be protective against traumatic injuries such as brachial plexus injury, in macrosomic babies born to mothers with diabetes.</span></li><li><span style=\"font-size:12pt;\">Elective LSCS is recommended when the estimated fetal weight is &gt; 4.5kg in diabetic mothers to reduce the incidence of birth trauma</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. In a patient being planned for induction of labor, night dose of intermediate insulin is given as planned, and the morning dose is withheld</strong>: In a planned delivery, although the bedtime dose of intermediate-acting insulin is given, it is recommended that the morning dose must be withheld</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Insulin Management for Labor Induction or Scheduled Cesarean Delivery</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/untitled-236.jpg\" alt=\"\" width=\"900\" height=\"271\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. In active labor, if RBS &lt;70 mg%, D5 is started at 100-150 ml/h till the RBS is &gt;100 mg%:</strong> In active labor, if RBS (Random blood glucose) &lt;70 mg%, D5 (5% dextrose) is started at 100-150 ml/h till the RBS is &gt;100 mg%. Before initiation of labor, normal saline is used for iv infusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Capillary blood glucose monitoring levels are kept at fasting- 95 mg%; 1 h postprandial- 140 mg%; 2 h postprandial: 120 mg%:</strong> Self-monitoring of capillary blood glucose is advised in a pregnant woman diagnosed with diabetes. The glucose goals recommended are:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Fasting: 95 mg/dL</strong></span></li><li><span style=\"font-size:12pt;\"><strong>1 h postprandial: 140 mg/dL</strong></span></li><li><span style=\"font-size:12pt;\"><strong>2 h postprandial: 120 mg/dL</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Elective C-section can reduce the incidence of brachial plexus injury in pregnancies complicated by diabetes, especially in cases of fetal macrosomia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 2807, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23994,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54772,
      "choices": [
        {
          "id": 218553,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Estrone</span></span></p>"
        },
        {
          "id": 218554,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Estradiol</span></span></p>"
        },
        {
          "id": 218555,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Estriol</span></span></p>"
        },
        {
          "id": 218556,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Conjugated equine estrogen</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The most potent natural estrogen is? (INICET MAY 2024)</span></span></span></p>",
      "unique_key": "Q5996201",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585208,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Estradiol</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Estrogens play a crucial role in the development and regulation of the female reproductive system and secondary sexual characteristics. Among the natural estrogens, estradiol is the most potent. Estradiol is primarily produced by the ovaries and is the predominant estrogen during the reproductive years of a woman. It has the highest affinity for estrogen receptors, making it the most effective at eliciting estrogenic responses in the body.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Estrone, on the other hand, is the main estrogen found in postmenopausal women and is less potent than estradiol. Estriol is the weakest of the three natural estrogens and is predominantly produced during pregnancy. Conjugated equine estrogen is a mixture of estrogens derived from the urine of pregnant mares and is less potent than estradiol.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Therefore, estradiol is considered the most potent natural estrogen due to its strong affinity for estrogen receptors and its significant role in reproductive physiology.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Estrone:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Although it is a natural estrogen, estrone is less potent than estradiol. It is primarily found in postmenopausal women and does not exert the same level of estrogenic activity as estradiol.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Estriol:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This estrogen is the least potent of the natural estrogens and is mainly produced during pregnancy. It has a much lower affinity for estrogen receptors compared to estradiol.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Conjugated equine estrogen:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is a semi-synthetic mixture of estrogens obtained from horses. While it is used in hormone replacement therapy, its potency is lower than that of estradiol and it is not considered a single natural estrogen.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Estradiol is the most potent natural estrogen, especially during a woman&rsquo;s reproductive years, due to its high receptor affinity and significant physiological effects</span></span></span></p>",
      "correct_choice_id": 218554,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20482,
      "choices": [
        {
          "id": 81890,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">10 to 12 weeks</span></span></span></p>"
        },
        {
          "id": 81891,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">8 to 10 weeks</span></span></span></p>"
        },
        {
          "id": 81892,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">After 14 weeks</span></span></span></p>"
        },
        {
          "id": 81893,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">After 20 weeks</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A primigravida presents to you in her early pregnancy with anemia. She is 7 weeks pregnant as seen on ultrasound. Her haemoglobin level is 9 g/dL. When should the iron supplements be started for her?</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"> (NEET PG 2023)</span></span></span></p>",
      "unique_key": "Q5238038",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585159,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) 8 to 10 weeks</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prophylaxis for anemia in pregnancy is generally started at 14 weeks and continued for 180 days. However, the given question indicates that the patient has moderate anemia and requires immediate treatment. Among the provided options, the earliest time to start iron supplements is 8 to 10 weeks, making this the correct answer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">According to the Anemia Mukt Bharat campaign, the severity of anemia is classified as follows:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mild: 10-10.9 g%</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Moderate: 7-9 g%</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Severe: &lt;7 g%</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Testing and Treating Mild and Moderate Anemia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mild anemia or moderate anemia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Give 2 tablets of iron.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Late presentation in pregnancy or inability to tolerate oral iron:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Administer parenteral iron, such as iron carboxymaltose (FeCM).</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treating Severe Anemia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hemoglobin &lt; 7 g%:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Administer iron carboxymaltose.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Late presentation in the third trimester with severe anemia or hemoglobin &lt; 5 g%:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Admit the patient for further management.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. 10 to 12 weeks</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While this is an earlier time frame than the standard prophylactic start, it is not as early as 8 to 10 weeks, which is necessary for moderate anemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. After 14 weeks:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is the standard time for starting prophylactic iron supplements but is too late for a patient with moderate anemia who requires immediate treatment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. After 20 weeks:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is much too late for initiating treatment for anemia, especially for a patient with moderate anemia needing earlier intervention.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In cases of moderate anemia (Hb 7-9 g/dL) in early pregnancy, iron supplements should be started as early as 8 to 10 weeks to ensure timely treatment.</span></span></span></p>",
      "correct_choice_id": 81891,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5703,
      "choices": [
        {
          "id": 22784,
          "text": "<p><span style=\"font-size:12pt;\">Estimate serum estradiol values</span></p>"
        },
        {
          "id": 22785,
          "text": "<p><span style=\"font-size:12pt;\">Give progesterone and stop after 10 days for withdrawal bleeding</span></p>"
        },
        {
          "id": 22786,
          "text": "<p><span style=\"font-size:12pt;\">Check USG for polycystic ovaries</span></p>"
        },
        {
          "id": 22787,
          "text": "<p><span style=\"font-size:12pt;\">Do a urine pregnancy test</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old female came with complaints of 4 months amenorrhea. Her FSH and LH were elevated above the normal value, thyroid function tests were normal. Which is the next step in management?&nbsp;(INICET MAY 2017)</span></p>",
      "unique_key": "Q8847365",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585190,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Give progesterone and stop after 10 days for withdrawal bleeding</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Since LH and FSH are elevated above the normal value, the possibility of a pregnancy can be ruled out as FSH and LH levels fall to very low levels in pregnancy</span></li><li><span style=\"font-size:12pt;\">The first step in evaluation of secondary amenorrhoea after ruling out pregnancy is to do a progesterone challenge test i.e. to see if she bleeds after a challenge of progesterone.</span></li><li><span style=\"font-size:12pt;\">If she bleeds, the diagnosis is anovulation like in PCOS</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Estimate serum estradiol values</strong>: Serum estradiol level measurement has no role in evaluation of secondary amenorrhoea</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Do a urine pregnancy test</strong>: FSH levels in pregnancy are very very low so pregnancy is unlikely; otherwise the most common cause of secondary amenorrhoea is pregnancy</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Check USG for Polycystic ovaries</strong>: This is done if the patient bleeds following progesterone withdrawal as it determines the cause of anovular cycles</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Secondary amenorrhea is defined as a period of amenorrhoea of 6 months</span></li><li><span style=\"font-size:12pt;\">Pregnancy needs to be ruled out</span></li><li><span style=\"font-size:12pt;\">The most common cause of secondary amenorrhea after ruling out pregnancy is anovulation (PCOS) which can be determined by the progesterone withdrawal test</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 457, DC Dutta’s Textbook of Gynecology 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 22785,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6072,
      "choices": [
        {
          "id": 24258,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1st trimester USG is the best assessment</span></span></span></p>"
        },
        {
          "id": 24259,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calculated from the last day of the last menstrual period</span></span></span></p>"
        },
        {
          "id": 24260,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In an IVF pregnancy, day of embryo transfer/day of fertilization is needed to calculate POG</span></span></span></p>"
        },
        {
          "id": 24261,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Crown-rump length is the best measure of period of gestation in the first trimester</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the wrong statement regarding the period of gestation calculation:</span></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;</span></span></span>(INICET NOV 2022)</p>",
      "unique_key": "Q4768891",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585185,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Calculated from the last day of the last menstrual period</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gestational age or period of gestation (POG) refers to the duration of pregnancy calculated from the first day of last menstrual period </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calculating the EDD: </span></strong></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal duration of pregnancy: 280 days (40 weeks)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calculating the EDD: <strong>Naegele&rsquo;s formula</strong>. To the LMP (1<sup>st</sup> day of the last menstrual day) </span></span></span>\r\n\t\t<ul>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Add 9 months + 7 days</span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Subtract 3 months and add 7 days</span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For IVF Pregnancies: add 38 weeks to the date of the embryo transfer</span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dating the pregnancy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> If discrepancy in dates/ unsure of LMP; the best way to determine the dating is by ULTRASOUND</span></span></span>\r\n\t\t<ul>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1st trimester CRL: most accurate (till 14 weeks)</span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BPD in the 2nd trimester</span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. 1st trimester USG is the best assessment</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Correct, because the 1st trimester USG provides the most accurate dating method.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. In an IVF pregnancy, day of embryo transfer/day of fertilization is needed to calculate POG</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Correct, because calculating gestational age in IVF pregnancies relies on the day of embryo transfer or fertilization.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Crown-rump length is the best measure of period of gestation in the first trimester</strong>: Correct, because CRL is the best measure for assessing the period of gestation in the first trimester.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gestational age is calculated from the first day of the last menstrual period (LMP), not the last day.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: William&rsquo;s textbook of obstetrics 24<sup>th</sup> edition pg, Dutta&rsquo;s 108, 109, textbook of obstetrics 8<sup>th</sup> edition pg127</span></strong></span></span></p>",
      "correct_choice_id": 24259,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44017,
      "choices": [
        {
          "id": 175727,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oral contraceptive pills (OCPs)</span></span></span></p>"
        },
        {
          "id": 175728,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Functional ovarian cyst</span></span></span></p>"
        },
        {
          "id": 175729,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nulliparity</span></span></span></p>"
        },
        {
          "id": 175730,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polycystic ovary syndrome (PCOS)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is a risk factor for progression to borderline ovarian tumor?</span></span>&nbsp;(INICET NOV 2023)</p>",
      "unique_key": "Q4629286",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585207,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Nulliparity</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nulliparity is associated with a slightly increased risk of ovarian tumors, including borderline ovarian tumors, possibly due to uninterrupted ovulation and hormonal fluctuations.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Oral contraceptive pills (OCPs:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Oral contraceptive pills (OCPs) are known to reduce the risk of ovarian cancer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Functional ovarian cyst:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Functional ovarian cysts typically do not progress to ovarian tumors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Polycystic ovary syndrome (PCOS):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Polycystic ovary syndrome (PCOS) has not been strongly linked with increased risk of borderline ovarian tumors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nulliparity is recognized as a risk factor for borderline ovarian tumors, highlighting the influence of reproductive factors on ovarian health.</span></span></span></p>",
      "correct_choice_id": 175729,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5896,
      "choices": [
        {
          "id": 23554,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hysterectomy</span></span></span></p>"
        },
        {
          "id": 23555,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Conization</span></span></span></p>"
        },
        {
          "id": 23556,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Colposcopy and biopsy</span></span></span></p>"
        },
        {
          "id": 23557,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follow-up after 6 months</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old woman is diagnosed with carcinoma in situ (CIS) of the cervix and no obvious macroscopic growth. What is the next line of management?&nbsp;</span></span>(INICET NOV 2020)</p>",
      "unique_key": "Q7289097",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585163,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Conization</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carcinoma in situ is Stage 0 Cancer. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It means it involves the entire thickness of the epithelium without invasion of the basement membrane. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This should be followed by a conization as the woman is 30 years old and conization will provide us with a biopsy specimen as well as be curative</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If family is complete/ elderly patient, simple hysterectomy should be done</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment for Different stages of cervical cancer </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/30/untitled-278.jpg\" style=\"height:396px; width:900px\" /></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Hysterectomy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While effective, it is more invasive and typically reserved for those who have completed childbearing or for older patients.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Colposcopy and biopsy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is used for further evaluation but is not the definitive treatment for CIS when the diagnosis is already confirmed.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Follow-up after 6 months:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Follow-up without intervention is not appropriate for CIS due to the risk of progression to invasive cancer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For a young woman diagnosed with carcinoma in situ (CIS) of the cervix, conization is the recommended next step, providing both diagnostic and therapeutic benefits.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: FIGO Revised Staging of Cervical Cancer, Berek and Novak&rsquo;s Gynecology 15<sup>th</sup> Edition, Dutta&rsquo;s textbook of Gynecology 8<sup>th</sup> edition page367, </span></strong></span></span></p>",
      "correct_choice_id": 23555,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5960,
      "choices": [
        {
          "id": 23810,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hysteroscopy</span></span></span></p>"
        },
        {
          "id": 23811,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Saline infusion sonography</span></span></span></p>"
        },
        {
          "id": 23812,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Hysterosalpingography</span></span></span></p>"
        },
        {
          "id": 23813,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Transvaginal ultrasonography</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A female patient has a history of three miscarriages. Identify the investigation that was done from the image shown below?</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> (NEET PG 2021)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/15/2.jpg\" style=\"height:275px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q7278187",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585192,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Hysterosalpingography </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is an image of a Hysterosalpingogram (HSG)</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An HSG is used to</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Delineate uterine anomalies.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometrial cavity lesions like polyps, adhesions</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tubal patency in infertility</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Hysteroscopy</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Hysteroscopy appears like this image. Using fluid media to distend the uterine cavity, a hysteroscope can visualize the inside of the uterine cavity. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/15/3.jpg\" style=\"height:203px; width:300px\" /></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Saline infusion sonography</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Saline infusion sonography: This is an ultrasound-based investigation, wherein saline is injected in the uterine cavity and this helps detect intra-uterine space occupying lesions and appears like this:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/15/4.jpg\" style=\"height:171px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Transvaginal ultrasound</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This appears like this:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/15/5.jpg\" style=\"height:225px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><strong>Educational Objective:</strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A Hysterosalpingogram (HSG) is an X-ray procedure used to delineate uterine anomalies, identify endometrial cavity lesions, and assess tubal patency in cases of infertility.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 588, DC Dutta&rsquo;s Textbook of Gynecology 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23812,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5795,
      "choices": [
        {
          "id": 23151,
          "text": "<p><span style=\"font-size:12pt;\">6, 11, 16, 18, 20, 23, 35, 42, 52</span></p>"
        },
        {
          "id": 23152,
          "text": "<p><span style=\"font-size:12pt;\">6, 11, 16, 19, 23, 33, 45, 58</span></p>"
        },
        {
          "id": 23153,
          "text": "<p><span style=\"font-size:12pt;\">6, 11, 16, 18, 32, 34, 45, 52, 58</span></p>"
        },
        {
          "id": 23154,
          "text": "<p><span style=\"font-size:12pt;\">6, 11, 16, 18, 31, 33, 45, 52, 58</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">HPV nonavalent vaccine is active against which of the following serotypes?&nbsp;</span>(INICET MAY 2018)</p>",
      "unique_key": "Q2700026",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585172,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) 6, 11, 16, 18, 31, 33, 45, 52, 58</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">HPV Vaccines available are:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">Cervarix (Bivalent): 16, 18</span></li><li><span style=\"font-size:12pt;\">Gardasil (Quadrivalent): 6, 11, 16, 18</span></li><li><span style=\"font-size:12pt;\">Nonavalent: (Gardasil 9 or HPV9): 6, 11, 16, 18,31,33,45,52,58.</span></li><li><span style=\"font-size:12pt;\">Cervavac (India’s indigenous HPV vaccine): Quadrivalent: 6,11,16,18</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">HPV nonavalent vaccine is active against serotypes <strong>6, 11, 16, 18, 31, 33, 45, 52, 58.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref:&nbsp;</strong></span><a href=\"https://www.who.int/news/item/20-12-2022-WHO-updates-recommendations-on-HPV-vaccination-schedule\"><span style=\"font-size:12pt;\"><strong><u>https://www.who.int/news/item/20-12-2022-WHO-updates-recommendations-on-HPV-vaccination-schedule</u></strong></span></a></p>",
      "correct_choice_id": 23154,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5868,
      "choices": [
        {
          "id": 23442,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Minute volume decreases by 50%</span></span></span></p>"
        },
        {
          "id": 23443,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Residual volume increases</span></span></span></p>"
        },
        {
          "id": 23444,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FRC decreases</span></span></span></p>"
        },
        {
          "id": 23445,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Total lung capacity increases</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The correct statement regarding the physiological changes in the respiratory system in pregnancy?&nbsp;</span></span>(INICET NOV 2019)</p>",
      "unique_key": "Q2133632",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585203,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) FRC decreases</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/30/untitled-277.jpg\" style=\"height:644px; width:900px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Minute volume decreases by 50%:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is incorrect. In fact, minute ventilation, which is the total volume of air inspired in a minute, increases by 40% during pregnancy due to an increase in tidal volume.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Residual volume increases:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is incorrect. Residual volume, which is the volume of air remaining in the lungs after maximal expiration, decreases by 20-25% during pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Total lung capacity increases:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is incorrect. Total lung capacity, which is the maximum amount of air the lungs can hold, is either unaffected or slightly decreased (by about 5%) during pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Functional Residual Capacity (FRC) decreases by approximately 22% during pregnancy due to the upward displacement of the diaphragm by the enlarging uterus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: William&rsquo;s textbook of obstetrics 26<sup>th</sup> edition pg189, Dutta&rsquo;s textbook of obstetrics 8<sup>th</sup> edition pg 6</span></strong></span></span></p>",
      "correct_choice_id": 23444,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5870,
      "choices": [
        {
          "id": 23450,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">APLA syndrome</span></span></span></p>"
        },
        {
          "id": 23451,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Congenital heart defects</span></span></span></p>"
        },
        {
          "id": 23452,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SLE</span></span></span></p>"
        },
        {
          "id": 23453,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hemolytic anemia</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">On finding a congenital heart block in a fetus which of the following conditions would you evaluate for in the mother?&nbsp;</span></span>(INICET NOV 2019)</p>",
      "unique_key": "Q6419106",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585205,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) SLE</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Congenital heart block (CHB) in a fetus is often associated with maternal autoimmune conditions, particularly Systemic Lupus Erythematosus (SLE). This condition is related to the presence of maternal antibodies against the SS-A (Ro) or SS-B (La) antigens. These antibodies can cross the placenta and affect the fetal heart, leading to congenital heart block. Therefore, if a congenital heart block is detected in a fetus, it is essential to evaluate the mother for SLE.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neonatal lupus erythematosus, a subtype of lupus erythematosus, is caused by the transplacental passage of these maternal antibodies. The most frequent clinical manifestations in the neonate include congenital heart block and cutaneous lesions. Fetal echocardiography is recommended between 18 and 26 weeks of gestation in pregnancies where these antibodies are present to monitor for congenital heart block.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. APLA syndrome:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Antiphospholipid antibody syndrome (APLA) is associated with increased risks of miscarriages, intrauterine fetal demise (IUFD), and preterm births. However, it is not specifically associated with congenital heart block in the fetus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Congenital heart defects:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Women with certain congenital cardiac defects may have an increased chance of giving birth to children with similar defects, such as Marfan syndrome, aortic stenosis, ventricular septal defect (VSD), atrial septal defect (ASD), and coarctation of the aorta. However, these conditions are not directly linked to congenital heart block caused by maternal antibodies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Hemolytic anemia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Hemolytic anemias, such as thalassemia, sickle cell anemia, and hereditary spherocytosis, are inherited conditions but are not associated with congenital heart block in the fetus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Congenital heart block (CHB) in a fetus is associated with maternal antibodies to SS-A (Ro) or SS-B (La), commonly seen in Systemic Lupus Erythematosus (SLE).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Dutta&rsquo;s textbook of obstetrics 8<sup>th</sup> edition pg 722</span></strong></span></span></p>",
      "correct_choice_id": 23452,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47226,
      "choices": [
        {
          "id": 188515,
          "text": "<p><span style=\"font-size:12.0pt;\">Fetal anomaly</span></p>"
        },
        {
          "id": 188516,
          "text": "<p><span style=\"font-size:12.0pt;\">Minor</span></p>"
        },
        {
          "id": 188517,
          "text": "<p><span style=\"font-size:12.0pt;\">Rape</span></p>"
        },
        {
          "id": 188518,
          "text": "<p><span style=\"font-size:12.0pt;\">Contraceptive failure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">MTP after 24 weeks is done for?&nbsp;</span>(FMGE JULY 2023)</p>",
      "unique_key": "Q4881440",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585214,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Fetal anomaly</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Medical Termination of Pregnancy (MTP) after 24 weeks is permitted only in cases of substantial fetal anomalies. The MTP Act amendment of 2021 allows for this provision to ensure that pregnancies with severe and life-threatening fetal conditions can be terminated to prevent undue suffering for both the fetus and the parents.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The process involves a medical board, which is established at the district level or within medical colleges. This board typically includes a radiologist, a gynecologist, a pediatrician, and any relevant subspecialists depending on the nature of the anomaly. The board evaluates whether the fetal anomaly is substantial enough to warrant termination of the pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Minor</strong>: Termination for minors is allowed up to 24 weeks but not beyond.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Rape</strong>: Termination for pregnancies resulting from rape is allowed up to 24 weeks but not beyond.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Contraceptive failure</strong>: Termination due to contraceptive failure is allowed up to 20 weeks and, in some cases, up to 24 weeks but not beyond.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">MTP beyond 24 weeks is allowed only for substantial fetal anomalies, as determined by a medical board, to ensure the safety and well-being of the mother and to address severe fetal conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Indication for MTP -</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/04/screenshot-2024-06-04-164027_mqrKT4F.png\" alt=\"\" width=\"1000\" height=\"413\"></strong></span></p>",
      "correct_choice_id": 188515,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5739,
      "choices": [
        {
          "id": 22928,
          "text": "<p><span style=\"font-size:12pt;\">Tuboplasty</span></p>"
        },
        {
          "id": 22929,
          "text": "<p><span style=\"font-size:12pt;\">Hysteroscopy and laparoscopy-guided surgery</span></p>"
        },
        {
          "id": 22930,
          "text": "<p><span style=\"font-size:12pt;\">Hydrotubation</span></p>"
        },
        {
          "id": 22931,
          "text": "<p><span style=\"font-size:12pt;\">In-vitro fertilization</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 26-year-old woman underwent a workup for primary infertility. On hysterosalpingography, there was a bilateral cornual block. What is the next step in management?&nbsp;(INICET NOV 2017)</span></p>",
      "unique_key": "Q1328550",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585204,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Hysteroscopy and laparoscopy-guided surgery</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Cornual block, also known as proximal tubal obstruction, can be effectively managed with proximal tubal catheterization and cannulation, typically guided by hysteroscopy and laparoscopy. This method has about an 85% success rate in restoring tubal patency, making it the next logical step in management for a woman with a bilateral cornual block.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Key Points:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\"><strong>Cornual Block:</strong> Proximal tubal obstructions often require intervention to restore patency.</span></li><li><span style=\"font-size:16px;\"><strong>Hysteroscopy and Laparoscopy:</strong> These procedures allow for precise catheterization and cannulation to open the blocked tubes, leading to a high success rate.</span></li><li><span style=\"font-size:16px;\"><strong>Success Rate:</strong> Approximately 85% success in restoring tubal patency.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Tuboplasty:</strong> While tuboplasty is an option for distal tubal occlusion, it is not the first-line treatment for cornual block.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Hydrotubation:</strong> This procedure involves flushing the tubes with fluid but is <strong>less effective for treating</strong> cornual block compared to hysteroscopy and laparoscopy-guided surgery. Success rates are poor (15-30 %)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. In-vitro fertilization:</strong> IVF is typically considered when surgical interventions fail or are not suitable, particularly in women over 35 or those with severe tubal damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Cornual block in a young woman with primary infertility should be managed with hysteroscopy and laparoscopy-guided proximal tubal catheterization and cannulation to restore tubal patency before considering more invasive options like IVF.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ref: Page 1158, Berek and Novak’s Gynecology 15<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 22929,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}